<SEC-DOCUMENT>0001121404-24-000003.txt : 20240201
<SEC-HEADER>0001121404-24-000003.hdr.sgml : 20240201
<ACCEPTANCE-DATETIME>20240201094514
ACCESSION NUMBER:		0001121404-24-000003
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240201
DATE AS OF CHANGE:		20240201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanofi
		CENTRAL INDEX KEY:			0001121404
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				133529324
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31368
		FILM NUMBER:		24585281

	BUSINESS ADDRESS:	
		STREET 1:		46 AVENUE DE LA GRANDE ARMEE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75017
		BUSINESS PHONE:		33153774400

	MAIL ADDRESS:	
		STREET 1:		46 AVENUE DE LA GRANDE ARMEE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI-AVENTIS
		DATE OF NAME CHANGE:	20040826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI SYNTHELABO SA
		DATE OF NAME CHANGE:	20010104
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a6kcoverpagepressreleaseq4.htm
<DESCRIPTION>6-K
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i9cb5c84dfaa141fd8819cce0c4e4425f_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;6-K</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF FOREIGN PRIVATE ISSUER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO RULE&#160;13a-16&#160;OR&#160;15d-16</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDER THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the month of February 2024</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number&#58;&#160;001-31368</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANOFI</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Translation of registrant&#8217;s name into English)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">46, avenue de la Grande Arm&#233;e, 75017 Paris, FRANCE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices)</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant files or will file annual reports under cover Form&#160;20-F&#160;or Form&#160;40-F.</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form 20-F&#160;&#160;&#9746;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form&#160;40-F&#160;&#160;&#9744;</font></div><div style="margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2024, Sanofi issued the press release attached hereto as Exhibit 99.1 which is incorporated herein by reference.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit Index</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:18.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit No.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 99.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Press release dated February 1, 2024&#58; Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURES</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.635%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; February 1, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SANOFI</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#47;s&#47; Alexandra Roger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alexandra Roger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Head of Legal Corporate &#38; Finance</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressreleaseq42023english.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i46d0ead8d5c7481bac049465b79fb3e4_1"></div><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Press Release                                                              </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><img alt="imagea.jpg" src="imagea.jpg" style="height:45px;margin-bottom:5pt;vertical-align:text-bottom;width:165px"></div><div style="padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font><br></font></div><div style="padding-left:4.5pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:14pt;font-style:italic;font-weight:400;line-height:112%">Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Paris, February 1, 2024</font></div><div style="margin-bottom:3pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Q4 2023 sales growth of 9.3% at CER and business EPS</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:700;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%"> increase of 8.2% at CER</font></div><div style="padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.9pt">Specialty Care grew 13.7% driven by Dupixent and ALTUVIIIO launch performance, more than offsetting competition from generics of Aubagio in all key markets</font></div><div style="padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.9pt">Vaccines sales increased strongly (up 21.1%) mainly as a result of the unprecedented uptake of Beyfortus, reaching &#8364;410 million in the second quarter of its launch  </font></div><div style="padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.9pt">General Medicines decline moderated (down 2.4%), reflecting accelerated growth of core assets (up 6.3%), offset by lower sales of Lantus and non-core asset divestment</font></div><div style="padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.9pt">CHC rose 8.5% due to Digestive Wellness and Physical and Mental Wellness which benefited from Qunol acquisition</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Full-year 2023 delivered 5.3% sales growth and 5.4% business EPS growth at CER</font></div><div style="padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.9pt">Sales reached &#8364;43,070 million driven by Dupixent (&#8364;10,715 million, +34.0%, adding &#8364;2.8bn at CER), Vaccines (up 8.3%) which benefited from strong launch performance of Beyfortus (&#8364;547 millions) and CHC (+6.3%)</font></div><div style="padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.9pt">Business EPS</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of &#8364;8.11 down 1.8% on a reported basis and up 5.4% at CER </font></div><div style="padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.9pt">IFRS EPS of &#8364;4.31 (down 35.6%) mainly reflecting an impairment loss of technology assets resulting from de-prioritization of R&#38;D programs and a charge related to the liability remeasurement of expected future royalty payments on U.S. Beyfortus sales, which mainly occurred in Q4</font></div><div style="padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.9pt">Board held on January 31, proposes annual dividend of &#8364;3.76 an increase of 5.6%</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:15.1pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">R&#38;D transformation and Key milestones in Q4</font></div><div style="padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.9pt">Strong pipeline including record 12 blockbuster opportunities under clinical evaluation detailed at recent R&#38;D Day</font></div><div style="padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.9pt">Dupixent submitted for COPD (Chronic Obstructive Pulmonary Disease) in the U.S., EU, and China</font></div><div style="padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.9pt">Sarclisa delivered positive phase 3 results in 1L transplant-ineligible Multiple Myeloma (IMROZ)</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:15.1pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Progress on Corporate Social Responsibility strategy in Q4</font></div><div style="padding-left:15.1pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.35pt">Sanofi Global Health Unit announced three new investments through its Impact Fund to support healthcare start-ups in Sub-Saharan Africa</font></div><div style="padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.9pt">Sanofi at COP28&#58; supporting the decarbonization of healthcare systems</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:15.1pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Full-year 2024 business EPS guidance</font></div><div style="margin-bottom:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.9pt">Sanofi expects 2024 business EPS</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to remain roughly stable excluding the impact of an expected effective tax rate increase to 21% and decrease low single-digit</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> at CER including the higher expected tax rate, barring unforeseen major adverse events. Applying average January 2024 exchange rates, the currency impact on 2024 business EPS is estimated between -3.5% to -4.5%. </font></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Paul Hudson, Sanofi Chief Executive Officer, commented&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">&#8220;2023 marked a critical year on our journey to become a development-driven, tech-powered biopharma company committed to serving patients and accelerating growth. We have delivered another year of strong underlying performance of our core drivers in Specialty Care and Vaccines supported by the outstanding launch execution of Beyfortus, Altuviiio and Tzield. With scientific news flow at an all-time high, pipeline advances and 12 potential blockbusters in late-stage development including amlitelimab, frexalimab and tolebrutinib, our R&#38;D transformation has reached an inflection point on the road to industry leadership in immunology. Looking forward, we remain committed to investing in R&#38;D to fully unlock the value of our pipeline, powered by AI at scale, and continue to focus on our expected launch opportunities such as Dupixent in COPD. At the same time, we are taking steps to become a pure-play biopharma company with more than &#8364;10bn sales contribution from Pharma launches by 2030</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">.&#8221;</font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_4"></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.875%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IFRS net sales reported</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;10,919m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+1.8%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+9.3%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;43,070m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+0.2%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+5.3%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IFRS net income reported</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#8364;555m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-117.8%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">_</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;5,400m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-35.5%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IFRS EPS reported</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#8364;0.44</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-117.7%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">_</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;4.31</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-35.6%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:-4.05pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Free cash flow</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;3,496m</font></td><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+37.3%</font></td><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">_</font></td><td colspan="3" style="background-color:#f4f2f6;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;8,478m</font></td><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-0.1%</font></td><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business operating income</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;2,583m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-5.2%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+5.3%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;12,670m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-2.8%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+4.3%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:-4.05pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Business net income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;2,083m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-2.7%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+8.2%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;10,155m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-1.8%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+5.5%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:-4.05pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business EPS</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;1.66</font></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-2.9%</font></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+8.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;8.11</font></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-1.8%</font></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+5.4%</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:112%">Changes in net sales are expressed at constant exchange rates (CER) unless otherwise indicated (definition in Appendix 9). (1) In order to facilitate an understanding of operational performance, Sanofi comments on the business net income statement. Business net income is a non-IFRS financial measure (definition in Appendix 9). The consolidated income statement for Q4 2023 is provided in Appendix 3 and a reconciliation of reported IFRS net income to business net income is set forth in Appendix 4&#59; (2) 2023 business EPS was &#8364;8.11&#59; (3) Free cash flow is a non-IFRS financial measure (definition in Appendix 9). (4) Risk-adjusted net sales at CER . Already launched&#58; ALTUVIIIO, TZIELD, Sarclisa, Nexviazyme, Rezurock, Xenpozyme, Enjaymo, Cablivi&#59; Potential launches tolebrutinib, itepekimab, amlitelimab, frexalimab, rilzabrutinib, lunsekimig, Oral TNFR1si</font></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  1                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font><br></font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_7"></div><div><font><br></font></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">2023 fourth quarter and full-year summary</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">----------------------------</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Unless otherwise indicated, all percentage changes in sales in this press release are stated at CER</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">---------------------</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter of 2023, on a reported basis, Sanofi sales were &#8364;10,919 million, up 1.8%. Exchange rate movements had a negative effect of 7.5 percentage points. At CER, company sales were up 9.3%. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2023, Sanofi sales reached &#8364;43,070 million, up 0.2% on a reported basis. Exchange rate movements had a negative effect of 5.1 percentage points. At CER, company sales were up 5.3%.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Global Business Units</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fourth quarter 2023 net sales by Global Business Unit (growth at CER&#59; in &#8364; million&#59; % of total sales)</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><img alt="chart-22b986bd4a964014b65a.jpg" src="chart-22b986bd4a964014b65a.jpg" style="height:270px;margin-bottom:5pt;vertical-align:text-bottom;width:654px"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Business operating income</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter 2023 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (BOI) decreased 5.2% to &#8364;2,583 million. At CER, BOI increased 5.3%. The ratio of BOI to net sales decreased 1.7 percentage points (ppts) to 23.7% (down 0.9 ppts to 24.5% at CER). </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2023, BOI decreased 2.8% to &#8364;12,670 million. At CER, BOI increased 4.3%. The ratio of business operating income to net sales decreased 0.9 ppts to 29.4% (down 0.2 ppt to 30.1% at CER).</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Acquisitions and major collaborations</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On November 9, Sanofi announced the completion of closing for its collaborative agreements with Janssen Pharmaceuticals, Inc., a Johnson &#38; Johnson company, to develop and commercialize </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SP0282</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, the 9-valent vaccine candidate for extraintestinal pathogenic E. coli (ExPEC9V).</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On November 30, Sanofi announced the completion of closing for its collaborative agreements with Teva Pharmaceuticals, to develop and co-commercialize asset </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">TEV'574</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, currently in Phase 2b clinical trials for the treatment of ulcerative colitis and Crohn's disease, two types of inflammatory bowel disease.</font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_10"></div><div style="margin-top:9pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Sales by geographic region</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sanofi sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,876</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+10.1&#160;</font></td><td style="border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18,512</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+4.8&#160;</font></td><td style="border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,651</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+0.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,392</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of the World</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,392</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+14.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14,166</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+6.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;of which China</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">644&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+19.2&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">2,912&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+0.4&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:115%">See Appendix 9 for definitions of financial indicators</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  2                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">U.S., fourth-quarter</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 10.1% to &#8364;4,876 million. The strong performance of Dupixent as well as the launches of Beyfortus and ALTUVIIIO</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">were partially offset by the impact of generic competition on Aubagio and Mozobil as well as lower sales of influenza vaccines and Lantus.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Europe,</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> fourth-quarter sales were up 0.6% (to &#8364;2,651 million) driven by Dupixent, and the launch of Beyfortus, which were partially offset by the impact of generic competition on Aubagio and lower sales of Lantus and CHC.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Rest of World region, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">fourth-quarter sales increased 14.7% (to &#8364;3,392 million), mainly driven by Dupixent, General Medicines core assets, influenza Vaccines and CHC. Sales in </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">China</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> increased 19.2% to &#8364;644 million driven by Dupixent, Toujeo and Plavix. </font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_13"></div><div style="margin-bottom:6pt;margin-top:9pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Biopharma</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Biopharma segment includes the Global Business Units Specialty Care, General Medicines and Vaccines. Please also see Appendix 1 and 2 for the comprehensive segment reporting.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter, Biopharma sales increased 9.4% to &#8364;9,704 million, driven by Specialty Care (up 13.7%) and Vaccines (up 21.1%) while General Medicines decreased 2.4%.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, Biopharma sales increased 5.1% to &#8364;37,890 million driven by Specialty Care and Vaccines growth, partially offset by lower sales of non-core assets in General Medicines.</font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_16"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Specialty Care</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dupixent</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,990&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+31.3&#160;</font></td><td style="border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,715&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+34.0&#160;</font></td><td style="border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Aubagio</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-74.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">955&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-52.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Myozyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">&#47; Lumizyme</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">160&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-20.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">783&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-15.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Fabrazyme</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">242&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+9.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">991&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+11.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Cerezyme</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+5.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">687&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+9.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Eloctate</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-21.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">471&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-15.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Alprolix</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+6.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">540&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+11.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Aldurazyme</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+7.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">279&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+12.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nexviazyme&#47;Nexviadyme</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+115.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">425</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+126.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Jevtana</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-5.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-14.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Sarclisa</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+30.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">381&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+37.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Cablivi</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-3.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">227&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+10.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Xenpozyme</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+58.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+347.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ALTUVIIIO</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Enjaymo</font></div></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+109.1&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+240.9&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (collaboration with Regeneron) sales increased 31.3% to &#8364;2,990 million. In the U.S., Dupixent sales of &#8364;2,299 million (up 28.2%) were driven by continued strong demand in the approved indications&#58; atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), eosinophilic esophagitis and prurigo nodularis. Dupixent total prescriptions (TRx) increased 30% (y</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ear-over-year</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) and new-to-brand prescriptions (NBRx) grew 24%. In Europe, fourth-quarter Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales grew 32.5% to &#8364;329 million reflecting continued growth in AD, asthma and CRSwNP. In the Rest of World region, fourth-quarter sales reached &#8364;362 million, up 52.5%, driven mainly by sales in Japan and China. In 2023, Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sales reached &#8364;10,715 million, up 34.0%.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Aubagio</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sales decreased 74.0% in the fourth quarter to &#8364;121 million, reflecting competition from generics across all regions, including Europe where generics entered the market at the end of September 2023.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Fourth-quarter sales of the Pompe Franchise (</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Nexviazyme&#47;Nexviadyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> + </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Myozyme&#47;Lumizyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:107%">) were at &#8364;291 million (up 11.0%). Nexviazyme&#47;Nexviadyme sales were &#8364;131 million, up +115.4% (of which &#8364;76 million in the U.S.) driven by the conversion of Myozyme&#47;Lumizyme in the eligible Pompe population (late-onset disease) and by new patient accruals. Conversely, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Myozyme&#47;Lumizyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> sales decreased 20.4% to &#8364;160 million reflecting the conversion to Nexviazyme&#47;Nexviadyme. Nexviazyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#47;Nexviadyme sales now represent 45% of Global Pompe sales. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Fabrazyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> sales increased 9.2% to &#8364;242 million, mainly reflecting new patient accruals across all three geographic regions, partially offset by unfavorable shipment patterns in the Rest of the World region. </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  3                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Cerezyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#47;Cerdelga</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> sales were up 7.4% to &#8364;209 million, reflecting growth in high inflationary countries (Argentina and Turkey) in the Rest of World region.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Eloctate</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were &#8364;103 million in the fourth quarter, down 21.0%, reflecting the uptake of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ALTUVIIIO</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ALTUVIIIO</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, a once-weekly first-in-class high-sustained factor VIII therapy for hemophilia A that offers significant bleed protection, was launched at the end of March 2023 in the U.S. and generated sales of &#8364;94 million in the fourth quarter. ALTUVIIIO was launched in Japan in the fourth quarter.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Alprolix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were &#8364;142 million, up 6.4%, driven by the U.S., which largely offset lower sales to Sobi recorded in the Rest of World region.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Sarclisa</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were &#8364;103 million, up 30.2%, driven by strong growth in the U.S. and the Rest of the Word region. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Jevtana</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> sales decreased 5.7% to &#8364;77 million due to generic competition in Europe and lower sales in the U.S., reflecting increased competition. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Cablivi</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales decreased 3.2% to &#8364;58 million in the fourth quarter primarily reflecting lower sales in the U.S. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sales of</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> Xenpozyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> were &#8364;26 million in the fourth quarter driven by the U.S.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter sales of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Enjaymo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> were &#8364;23 million mainly generated in the U.S. and Japan. </font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_19"></div><div style="margin-bottom:6pt;margin-top:15pt"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General Medicines</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Core assets</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">2</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lovenox</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">263&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-0.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,125&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-8.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Toujeo</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">278&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+11.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,123&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+6.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Plavix</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">254&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+13.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">948&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+4.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thymoglobulin</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+5.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">478&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+14.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Praluent</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+26.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">422&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+15.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Multaq</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-12.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">344&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rezurock</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+44.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">310&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+54.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TZIELD</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">core assets</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 6.3% (to &#8364;1,576 million), mainly driven by the performance of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Plavix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rezurock</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Praluent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">partially offset by lower sales of Mozobil due to generic competition, which started in the U.S. in July 2023. In 2023, core asset sales increased by 3.3% to &#8364;6,270 million.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Lovenox</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sales remained roughly stable (-0.3%) to &#8364;263 million, reflecting biosimilar competition as well as VBP (Value Base Procurement) impact in China, which was largely offset by growth in some other countries in the rest of the World Region. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> sales increased 11.4% to &#8364;278 million driven by China where its market share now exceeds that of Lantus. In the U.S., sales decreased mainly due to a shift in channel mix, resulting in a lower average net price.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Plavix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">fourth quarter sales were up 13.1% to &#8364;254 million driven by China.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Praluent</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> fourth-quarter sales were &#8364;118 million, up 26.0%,</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">driven by Europe and the Rest of the Word regio</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">n.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sales of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rezurock</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> were &#8364;86 million, up 44.4% in the fourth quarter driven by new patient adoption and improved patient adherence in the U.S.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the fourth quarter, </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">TZIELD</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> sales were &#8364;10 million, reflecting the anticipated gradual ramp up in the U.S., which is supported by early patient identification programs. </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2023, consolidated sales of TZIELD were &#8364;25 million.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Mozobil </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sales were down 50.7% to &#8364;33 million in the fourth quarter, reflecting the entry of generic competition in the U.S. in July. Sanofi expects generic competition to enter the European market in 2024.</font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:115%">Sanofi has prioritized core assets in its General Medicines portfolio with differentiated and&#47;or established profiles that have significant opportunity for growth in key markets. </font></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  4                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Non-core assets </font></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">non-core assets sales </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">decreased 11.6% to &#8364;1,252 million, mainly due to lower sales of Lantus and divestments (-4.2 ppt). In 2023, non-core-asset sales decreased by 16.5% to &#8364;5,524 million.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were &#8364;277 million, down 24.9% in the fourth quarter. In the U.S., sales decreased 68.7% (to &#8364;34 million), reflecting lower net pricing as a result of a change in channel mix and a shelf-stock adjustment  in anticipation of the previously announced 2024 U.S. list price decrease. </font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_22"></div><div style="margin-top:15pt"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Vaccines</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:174%">Influenza vaccines</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">741&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-4.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,669&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-5.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:174%">Polio&#47;Pertussis&#47;Hib vaccines</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">434&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+3.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,165&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-0.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:174%">Meningitis, Travel and endemic vaccines </font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">242&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+10.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,170&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+0.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:174%">Booster vaccines </font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-1.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">598&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+5.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beyfortus</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">410&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">547&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Others</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-76.1%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">325&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+96.4%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Vaccines</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 21.1% (to &#8364;1,986 million) driven by strong Beyfortus uptake partly offset by lower Influenza vaccines sales compared to last year and COVID-19 vaccines sales recorded in the fourth quarter of 2022. In 2023, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Vaccines</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sales reached &#8364;7,474 million, up 8.3%.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Beyfortus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> sales reached &#8364;410 million in the fourth quarter, reflecting the progressive implementation of &#8220;All Infant Protection programs&#8221; in the U.S., France and Spain. In 2023, Beyfortus sales reached &#8364;547 million.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Influenza vaccines</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales decreased 4.0% to &#8364;741 million in the fourth quarter due to lower vaccination rates and increased competition in the U.S. Rest of the World region increased 80.7% as a result of favorable delivery phasing compared to fourth quarter of 2022. Full-year 2023 influenza sales decreased 5.5% to &#8364;2,669 million.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Polio&#47;Pertussis&#47;Hib</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (PPH) vaccines sales increased 3.4% to &#8364;434 million driven by the favorable Pentacel CDC buying pattern in the U.S. and increased sales in Rest of the World region. In the U.S., Vaxelis became market leader in the three doses primary series market at the end of 2023. Vaxelis in-market sales are not consolidated and the profits are shared equally between Sanofi and Merck &#38; Co.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Meningitis, Travel and endemic</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> vaccines sales increased 10.4% (to &#8364;242 million) reflecting favorable CDC buying pattern in the U.S. while the divestment of the Japanese Encephalitis vaccine in 2022 impacted the Rest of the World Region. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Booster</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> vaccines sales decreased 1.4% in the fourth quarter to &#8364;139 million, reflecting lower sales in the Rest of the World region.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_25"></div><div style="text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Biopharma business operating income</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (BOI) of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Biopharma</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> decreased 2.8% to &#8364;2,279 million. At CER, Biopharma BOI was up 6.2% reflecting higher gross profit more than offsetting lower capital gains as compared to the fourth quarter of 2022 and litigation-related reserves. The ratio of BOI to net sales decreased 1.2 ppts to 23.5% (24.0% at CER). </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2023 business operating income of Biopharma decreased 2.1% to &#8364;11,247 million (up 4.8% at CER). The ratio of BOI to net sales decreased 0.7 ppts to 29.7% (30.3% at CER). </font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><font><br></font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_28"></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:120%">R&#38;D update at the end of the fourth quarter 2023</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:9pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Regulatory update</font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:8.05pt">The supplemental Biologics License Application (sBLA) of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (dupilumab) in Chronic Obstructive Pulmonary Disease (COPD) in the U.S. was completed in December 2023 and for China in 2024, following its Marketing Authorization Application (MAA) submission in Europe. The submission was based on overwhelming positive results from an interim analysis of the Phase 3 replicate trial NOTUS, along with positive results from the previous Phase 3 trial BOREAS.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  5                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The NOTUS trial, evaluating </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> compared to placebo in adults currently on maximal standard-of-care triple inhaled therapy with uncontrolled COPD and evidence of type 2 inflammation, met its primary endpoint with overwhelming efficacy, showing significantly reduced exacerbations by 34% compared to placebo, confirming results from the landmark BOREAS pivotal trial. The results also proved that treatment with Dupixent led to rapid and significant improvements in lung function (by 139 mL from baseline in FEV1) compared to placebo (by 57 mL from baseline in FEV1) by 12 weeks and were sustained at 52 weeks.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:8.05pt">The U.S. Food and Drug Administration (FDA) accepted for review the sBLA of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Kevzara</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for the treatment of Polyarticular Juvenile Idiopathic Arthritis, with a PDUFA date of June 10, 2024.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:8.05pt">The National Medical Products Administration (NMPA) in China approved </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Beyfortus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (nirsevimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) in neonates and infants entering or during their first RSV season.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:8.05pt">The European Medicines Agency&#8217;s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive scientific opinion of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fexinidazole</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Winthrop as the first oral treatment of acute form of sleeping sickness (Trypanosoma brucei rhodesiense), a lethal form of this parasitic disease found in Eastern and Southern Africa, in adults and children six years of age or older and weighing at least 20 kg. </font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Portfolio update</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Phase 3&#58;</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">The IMROZ trial evaluating the investigational use of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Sarclisa</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> (isatuximab) in combination with standard-of-care bortezomib, lenalidomide and dexamethasone (VRd) met its primary endpoint at a planned interim analysis for efficacy, demonstrating statistically significant improvement in progression-free survival compared with VRd alone in transplant-ineligible patients with newly diagnosed multiple myeloma. The data will be the basis for future regulatory submission.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Additionally, the European Myeloma Network-sponsored IsKia Phase 3 trial investigating </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Sarclisa</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> in combination with carfilzomib, lenalidomide and dexamethasone (KRd) showed a statistically significant improvement in the rate of minimal residual disease negativity, compared with KRd alone, after autologous stem cell transplant consolidation in transplant-eligible patients with newly diagnosed multiple myeloma. The results were presented at the American Society of Hematology (ASH) 2023 annual meeting. </font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">The study evaluating the efficacy and safety of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> for the treatment of eosinophilic gastritis (EoG), had its first patients treated.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">The studies evaluating the efficacy and safety of subcutaneous </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">amlitelimab</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, our potential first and best-in-class novel investigational anti-OX40L mAb, compared to placebo in adults with moderate-to-severe atopic dermatitis (COAST 1 NCT06130566 and COAST 2 NCT06181435) had their first participants treated. These studies were initiated following positive results from the STREAM-AD Phase 2b study showing significantly improved signs and symptoms of moderate-to-severe AD in adults whose disease cannot be adequately controlled with topical medications or for whom topical medications are not a recommended treatment approach. These results were presented as part of a late-breaking session at the European Academia of Dermatology &#38; Venereology (EADV) 2023 congress.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">New data from </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">TZIELD</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> (teplizumab-mzwv) PROTECT study, evaluating the efficacy and safety, compared to placebo, of the therapy to slow the loss of beta cells and preserve beta cell function as measured by C-peptide, in children and adolescents aged 8-17 years with Stage 3 autoimmune type 1 diabetes, were presented at the International Society for Pediatric and Adolescent Diabetes (ISPAD) 2023 annual conference. Additionally, the full data set was simultaneously published in </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:110%">The New England Journal of Medicine</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">Two additional studies evaluating the efficacy and safety of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Rezurock</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> (belumosudil) for the treatment of chronic lung allograft dysfunction (ROCKaspire NCT06082037), and first line graft-versus-host disease (ROCKnrol-1 NCT06143891) were initiated.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">Following positive Phase 2b data from </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">frexalimab</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, our investigational first and best-in-class anti-CD40L mAb for the treatment of multiple sclerosis (MS), shared at the joint European&#47;Americas Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS-ACTRIMS) 2023 meeting, the two planned Phase 3 studies evaluating its efficacy and safety for the treatment of relapsing MS (FREXALT-1 NCT06141473) and nrSPMS (FREVIVA NCT06141486) had their first patients treated.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%;padding-left:8.05pt">SP0282</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, the Extraintestinal Pathogenic E. coli 9-valent Vaccine (ExPEC9V) entered our pipeline after the closing of the development agreement with Janssen Pharmaceuticals (NCT04899336).</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">The FDA issued a Complete Response Letter for the sBLA of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> in chronic spontaneous urticaria (CSU), stating that additional efficacy data are required to support an approval, while not identifying any issues with safety or manufacturing. The ongoing Study C of the Phase 3 trial </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  6                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">continues to enroll patients, with results expected in late 2024 that are anticipated to provide the additional efficacy data.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">An Independent Data Monitoring Committee found that </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">tusamitamab ravtansine</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> as a monotherapy did not meet its dual primary endpoint of progression-free survival compared to docetaxel. Despite an improved overall survival trend, termination of the program was based on non-improvement in PFS at the final analysis. Tusamitamab ravtansine had a similar safety profile as previously presented with a lower incidence of various important clinical categories of adverse events versus docetaxel. Trial participants will have the option to stay on their current therapy if they are benefitting, as deemed by their provider, or to transition to an appropriate standard-of-care therapy. Sanofi will continue exploring the potential of tusamitamab-based antibody-drug conjugates and CEACAM5 research in several types of cancer.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Phase 2&#58;</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">The study evaluating subcutaneous </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">amlitelimab</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> in adult participants with moderate to severe hidradenitis suppurativa (HS) started to treat its first patients (NCT06118099).</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">The study evaluating </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">frexalimab</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> in preservation of endogenous insulin secretion compared to placebo in adults and adolescents on top of insulin therapy (FABULINUS NCT06111586) had its first participants treated.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">Following positive data of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">SAR441566</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, our differentiated oral TNFR1 signaling inhibitor, showing potential for antibody-like efficacy with no serious adverse event in inflammatory diseases, two Phase 2 studies in psoriasis (SPECIFIC-PSO NCT06073119) and rheumatoid arthritis (SPECIFIC-RA NCT06073093) started to enroll their first participants.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">The Phase 2b study evaluating </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">lunsekimig</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, the anti-IL-13&#47;TSLP Nanobody</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:110%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> VHH with potential to break efficacy ceilings in type 2 inflammation and beyond, for the treatment of asthma (AIRCULES NCT06102005), has dosed its first patients.  </font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%;padding-left:8.05pt">SAR447189</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> (also known as TEV-48574), the anti-TL1A mAb with potential best-in-class efficacy, developed in collaboration with Teva Pharmaceuticals, entered our pipeline in Phase 2b for the treatment of inflammatory bowel disease (IBD) (NCT05668013).</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">The study evaluating the efficacy, safety, tolerability, and PK&#47;PD of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">SAR442501</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, an anti-FGFR3 antibody, for the treatment of achondroplasia had its first patients treated.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">New findings of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">SAR443820</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, a first-in-class oral investigational brain-penetrant RIPK1 inhibitor for the treatment of amyotrophic lateral sclerosis (ALS), were presented at the joint European&#47;Americas Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS-ACTRIMS) 2023 meeting.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">The study evaluating </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Sarclisa</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> in combination with chemotherapy in pediatric patients with relapsed&#47;refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (ISAKIDS) has fulfilled its pediatric investigation plan (PIP) as part of the overall clinical development plan and is terminated.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">The repeated dose-finding study of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Kevzara</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> in children and adolescents with systemic Juvenile Idiopathic Arthritis (SKYPS) is ongoing in EU and ROW, under the pediatric investigation plan (PIP) as part of the overall clinical development plan. Submission is currently planned for 2027. Given the integral nature of the project it is not detailed anymore on the overall Sanofi pipeline chart.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Phase 1&#58;</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">The study evaluating </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">SAR446422</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, an anti-CD28&#47;OX40 bispecific antibody being developed for the treatment of inflammatory indications, had its first participant treated.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">The study evaluating </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">SAR445953</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, an anti-CEACAM5&#47;Topo1 ADC being developed for the treatment of colorectal cancer (CRC), had its first participant treated (NCT06131840).</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">Positive previously shared Phase 1 results of the mRNA RSV OA monovalent laid the foundation for </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">SP0256</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, the mRNA RSV combination vaccine program being developed for the prevention of multiple infections in older adults, which had its first participant treated (NCT05639894).</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%;padding-left:8.05pt">SP0230</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">, the meningococcal ABCWY conjugate vaccine, including the Meningitis B component following positive Phase 1&#47;2 results shared at the Vaccines event, is being developed for the prevention of Meningitis, and treated its first participant.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:8.05pt">The three studies evaluating </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">SAR442257</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> (CD38&#47;CD28&#47;CD3 T-Cell engager), </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">SAR443216</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> (CD3&#47;CD28&#47;HER2 T-Cell engager), and </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">SAR445710</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> (anti-PDL1&#47;IL-15 fusion protein) were discontinued based on preliminary results.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">An update of the R&#38;D pipeline as of December 31, 2023, is available on our website</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">https&#58;&#47;&#47;www.sanofi.com&#47;en&#47;science-and-innovation&#47;research-and-development</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_31"></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  7                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Consumer Healthcare </font></div><div style="margin-bottom:1pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">Change </font></div><div style="text-align:right"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">at CER</font></div></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">Change </font></div><div style="text-align:right"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">at CER</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allergy</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-5.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">769&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cough &#38; Cold </font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-0.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">512&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+11.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pain Care</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">275&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+1.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,106&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+0.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Digestive Wellness</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">322&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+18.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,502&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+15.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physical and Mental Wellness</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">182&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+58.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">606&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+12.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Personal Care</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-6.4&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">550&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-3.2&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consumer Healthcare</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (CHC) sales were up 8.5% to &#8364;1,215 million supported by growth in the Rest of World region and the U.S. which includes the acquisition of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Qunol</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The divestments of non-core products had a negative impact of -2.3</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ppts</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, mainly reflected in the non-core&#47;others category in the fourth quarter. In 2023, total CHC</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sales reached &#8364;5,180 million, up 6.3%. Excluding divestments and Qunol acquisition, CHC organic sales growth was 4.8% in the fourth quarter, and 6.6% in 2023. </font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> U.S.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, fourth quarter CHC sales increased by 10.1% to &#8364;341 million driven by the consolidation of Qunol sales this quarter in Physical and Mental Wellness category more than offsetting lower Allegra demand. </font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Europe</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, fourth quarter CHC sales decreased by 5.4% to &#8364;353 million mainly due to lower sales of Cough &#38; Cold categories and Digestive Wellness as well as divestments of non-core products.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Rest of World</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, fourth quarter CHC sales increased 17.1% to &#8364;521 million, driven by strong performance of the Digestive Wellness category.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_34"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">CHC business operating income</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (BOI) of CHC increased 3.1% to &#8364;304 million. At CER, the BOI of CHC was up 22.7% mainly reflecting the consolidation of Qunol. The ratio of BOI to net sales increased 1.2 ppts to 25.0% (26.9% at CER) compared to the fourth quarter of 2022. </font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2023, BOI of CHC decreased 5.5% to &#8364;1,438 million. At CER, BOI of CHC grew 4.7% mainly driven by higher sales which more than offset OPEX growth. The ratio of BOI to net sales decreased 1.6 ppts to 27.8% (down 0.5 ppts to 28.9% at CER).</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  8                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_37"></div><div style="margin-top:9pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Corporate Social Responsibility update at the end of the fourth quarter 2023</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:102%">Access to healthcare</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Sanofi Global Health Unit announces three new investments through its Impact Fund to support</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">healthcare start-ups in Sub-Saharan Africa</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Sanofi Global Health Unit (GHU) Impact Fund completed three further investments in Q4.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Viebeg Technologies is leveraging its proprietary data and artificial intelligence (AI) technology to make quality medical equipment more accessible and affordable to healthcare providers with a &#8216;one-stop-shop&#8217; procurement platform, flexible payment terms, and a digital inventory management system to optimize stock and automate reorders. Viebeg currently operates in Rwanda, Democratic Republic of Congo, and Kenya, and plans to expand in additional countries. Sanofi&#8217;s investment will support Viebeg&#8217;s efforts to strengthen their pharmacy segment and to assess the opportunity to expand its product offering to drugs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">mPharma provides innovative services, such as vendor-managed inventory services, data analytics and primary care solutions for community pharmacies. mPharma currently operates in Ghana, Nigeria, Kenya, Uganda, Zambia and Rwanda. Sanofi investment in mPharma and in-house business expertise will support its expansion in countries including Togo, Benin, Tanzania and Uganda. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The third new investment with Dawa Mkononi, a wholesaler utilizing a business-to-business e-marketplace and last-mile delivery services, supports strengthening existing operations in Tanzania and expansion possibilities in Mozambique and Rwanda. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">EMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of sleeping sickness (rhodesiense)</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sleeping sickness, or human African trypanosomiasis (HAT), is usually fatal without treatment, and is transmitted by the bite of infected tsetse flies, which are found in 36 African countries. In December 2023, Sanofi, DNDi and the HAT-r-ACC consortium announced the CHMP (EMA) has adopted a positive scientific opinion of Fexinidazole Winthrop for the treatment in patients 6 years of age or older of both first-stage (haemo-lymphatic) and second-stage (meningo-encephalitic) Trypanosoma brucei (T.b.) rhodesiense sleeping sickness. A positive opinion of both stages of the more common form (T.b. gambiense, found in West and Central Africa) was adopted in 2018. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This second positive opinion demonstrates Sanofi&#8217;s 23 year commitment to develop innovative therapies to fight sleeping sickness and paves the way for updated WHO guidelines on the treatment of the T.b. rhodesiense form of sleeping sickness. Once the guidelines are updated, Foundation S, Sanofi&#8217;s philanthropic organization will donate Fexinidazole Winthrop to the World Health Organization.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Sanofi is committed to contribute to the elimination of sleeping sickness by 2030, supporting the WHO Neglected Tropical Diseases roadmap.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font></div><div style="text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Environment</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Sanofi at COP28&#58; supporting the decarbonization of healthcare systems</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Health was for the first time on the official agenda of the COP28 with a dedicated Health Day with 143 countries signing a declaration on climate and health. Sanofi, with a delegation led by CEO Paul Hudson, held discussions with health ministers, healthcare actors and NGOs willing to engage in low-carbon and climate resilient healthcare systems. Sanofi showcased its commitments on climate change and health, going beyond its own operations and Foundation S stressed the importance of channeling philanthropic funds to help vulnerable populations adapt to climate change.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a company committed to fight climate change and its impact on health, Sanofi has taken the lead of the Sustainable Markets Initiative (SMI) - Patient Care Pathways Working Group. In this context, Sanofi is working to decarbonize the delivery of healthcare that accounts for 45% of global healthcare systems emissions by&#58; </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">Re-thinking the delivery of care, creating healthcare systems that are low carbon, resilient and more equitable, and that detect disease early and provide access to high-quality therapies using the latest innovations. For example, by implementing an all-infant immunization policy, the emission of the current management of RSV infections in some countries could be reduced up to 68%.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">Advancing transparency in how we collectively contribute to actioning real change that improves health outcomes. For example, by setting up a standardized, data-driven Life Cycle Assessment framework (LCA) to measure the environmental footprint of Sanofi&#8217;s products &#8211; from manufacturing and supply chain to the end-life of the product. </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  9                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Sanofi&#8217;s strategy to contribute to the fight against climate change and its impact on people&#8217;s health is grounded in two focus areas&#58;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">Reducing the impact of its activities and products on the environment&#58; between 2019 and 2023 we reduced our scope 1 and 2 carbon emissions by 38%, achieving top tier internationally recognized scores in the mitigation of climate change impact. Sanofi is implementing an action plan to arrive at net zero emissions by 2045.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">Bringing innovative, science-based solutions to tackle new or existing diseases exacerbated by climate change, especially in heavily affected areas such as respiratory diseases, allergies, diabetes, cardiovascular disease, or infectious diseases. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">ESG ratings</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Sanofi&#8217;s DJSI ranking improved with a score of 79&#47;100</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This achievement places Sanofi among the top-performing companies of the DJSI index and enables its inclusion in the DJSI World and DJSI Europe indexes. The improvement was driven both by a reduction of the negative score impact of a product-related controversy due to increased transparency on the issue and by performance increases in the Governance and Environmental dimensions.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">S&#38;P ESG rating update   </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Latest Sanofi ESG rankings&#58;</font></div><div style="text-align:justify"><img alt="capturedecran2024-01x23a18a.jpg" src="capturedecran2024-01x23a18a.jpg" style="height:330px;margin-bottom:5pt;vertical-align:text-bottom;width:716px"></div><div><font><br></font></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  10                   </font></div></div></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_40"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Fourth-quarter and full-year 2023 financial results</font></div><div style="margin-top:3pt"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Business Net Income</font><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:7.8pt;font-weight:700;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">3</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter of 2023, Sanofi generated</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> net sales</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of &#8364;10,919 million, an increase of 1.8% (up 9.3% at CER). Full-year 2023 net sales were &#8364;43,070 million, up 0.2% (up 5.3% at CER).</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">other revenues</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> increased 75.4% (up 90.8% at CER) to &#8364;1,282 million, including higher VaxServe sales of non-Sanofi products of &#8364;711 million (up 82.8% at CER) as well as &#8364;411 million COVID-19 related revenues. In 2023, other revenues increased 41.1% (up 50.0% at CER) to &#8364;3,374 million, including VaxServe sales of non-Sanofi products of &#8364;2,167 million (up 43.8% at CER) and COVID-19 vaccine related revenues (&#8364;505 million).</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Gross Profit</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> increased 5.8% (up 13.5% at CER) to &#8364;8,167 million. The gross margin ratio increased 2.8 ppts to 74.8% (74.8% at CER) compared with the same period of 2022. This increase mainly reflected an improvement of the Biopharma gross margin ratio (from 73.3% to 76.5%) due to favorable Specialty Care product mix, as well as the COVID-19 related revenues and was partially offset by the impact of generic competition on Aubagio and lower net pricing of Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">in the U.S. CHC gross margin ratio decreased from 61.8% to 61.5% due to currency effect and was up 0.2 ppt at CER benefiting from Qunol consolidation. In 2023, the gross margin ratio increased 1.1 ppts to 74.8% (74.9% at CER) driven by Biopharma which benefited from COVID-19 vaccine related revenues. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Research and Development </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(R&#38;D)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">expenses increased 2.7% to &#8364;1,872 million in the fourth quarter. At CER, R&#38;D expenses were up 6.6%, reflecting increased expenses in Vaccines. In 2023, R&#38;D expenses increased 0.3% to &#8364;6,728 million (up 3.0% at CER). </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">selling general and administrative expenses</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (SG&#38;A) increased 1.2% to &#8364;2,931 million. At CER, SG&#38;A expenses were up 7.4%, reflecting increased commercial investments and launch costs in Specialty Care and Vaccines as well as higher CHC commercial expenses. In the fourth quarter, the ratio of SG&#38;A to sales decreased 0.2 ppt to 26.8% compared to the prior year. In 2023, SG&#38;A expenses increased 1.9% to &#8364;10,692 million (up 6.1% at CER) and the ratio of SG&#38;A to sales was 0.4 percentage point higher at 24.8% compared to 2022.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter and full-year 2023 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">operating expenses</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> were &#8364;4,803 million (up 1.8% and up 7.1% at CER) and &#8364;17,420 million (up 1.3% and 4.9% at CER), respectively.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">other current operating income net of expenses</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was -&#8364;821 million compared to -&#8364;276 million in the fourth quarter of 2022. Other current operating income net of expenses included an expense of &#8364;889 million (compared to an expense of &#8364;659 million in the fourth quarter of 2022) corresponding to the share of profit to Regeneron from the monoclonal antibodies Alliance, the share of profit paid by Regeneron towards development costs and the reimbursement of commercialization-related expenses incurred by Regeneron. In the fourth quarter and full-year 2023, this line also included &#8364;149 million and &#8364;651 million of capital gains related to portfolio streamlining, respectively, compared to &#8364;227 million and &#8364;615 million in the same periods of 2022. In the fourth quarter, this line also included litigation-related reserves. Sanofi expects the amount of capital gains from portfolio streamlining to exceed &#8364;500 million in 2024. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter and full-year 2023 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">share of profit from associates </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">was &#8364;47 million and &#8364;122 million, respectively, compared to &#8364;6 million and &#8364;88 million in the same periods of 2022 and included the share of U.S. profit related to Vaxelis. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (BOI) decreased 5.2% to &#8364;2,583 million. At CER, BOI increased 5.3%. The ratio of BOI to net sales decreased 1.7 ppts to 23.7% (and down 0.9 ppts at CER). In 2023, business operating income was &#8364;12,670 million, down 2.8% (up 4.3% at CER). In 2023, the ratio of business operating income to net sales decreased 0.9 percentage points to 29.4% (30.1% at CER).</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Net financial expenses</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> were &#8364;49 million and &#8364;181 million in the fourth quarter and full-year 2023, respectively, compared to &#8364;28 million and &#8364;234 million in the same periods of 2022. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter 2023 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">effective tax rate</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> decreased to 18.1% from 20.6% in the fourth quarter of 2022 which led the full-year 2023 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">effective tax rate </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">of 18.8% compared to 19.3% in 2022. Sanofi expects its effective tax rate to be around 21% in 2024.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">business net income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> decreased 2.7% to &#8364;2,083 million and increased 8.2% at CER. The ratio of business net income to net sales decreased 0.9 ppts to 19.1% compared to the fourth quarter of 2022 (down 0.2 ppts at CER). In 2023, business net income decreased 1.8% to &#8364;10,155 million and increased 5.5% at CER. The ratio of business net income to net sales decreased 0.5 ppt to 23.6% compared to 2022 (stable at CER).</font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">ee Appendix 3 for 2023 fourth-quarter consolidated income statement&#59; see Appendix 9 for definitions of financial indicators, and Appendix 4 for reconciliation of IFRS net income reported to business net income</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">. </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  11                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter of 2023,</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> business earnings per share</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(EPS) was &#8364;1.66, down 2.9% on a reported basis (up 8.2% at CER). The average number of shares outstanding was 1,253.6 million compared to 1,254.0 million in the fourth quarter of 2022. In 2023, business earnings per share</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.47pt;font-weight:400;line-height:115%;position:relative;top:-3.48pt;vertical-align:baseline">8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was &#8364;8.11, down 1.8% on a reported basis and up 5.4% at CER. The average number of shares outstanding was 1,251.7 million compared to 1,251.9 million in 2022.</font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_43"></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Reconciliation of IFRS net income reported to business net income (see Appendix 4) </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2023, the IFRS net income was &#8364;5,400 million. The main items excluded from the business net income were&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">An amortization charge of &#8364;2,172 million related to fair value remeasurement on intangible assets (primarily Bioverativ&#58; &#8364;633 million, Genzyme&#58; &#8364;405 million, Boehringer Ingelheim CHC business&#58; &#8364;184 million, Ablynx&#58; &#8364;168 million, Kadmon&#58; &#8364;156 million, Provention Bio&#58; &#8364;144 million and Beyfortus&#58; &#8364;76 million) and to intangible assets from separate acquisitions - measured initially at acquisition cost (licenses&#47;products)&#58; &#8364;80 million. These items have no cash impact on the Company.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">An impairment charge of &#8364;896 million of which &#8364;877 million recorded in the fourth quarter and reflecting the impact of the strategic decision to de-prioritize some R&#38;D programs, notably linked to the NK cell and PRO-XTEN technology platforms.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">Restructuring costs and similar items of &#8364;1,490 million of which &#8364;684 million recorded in the fourth quarter related to streamlining initiatives.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">A financial charge of &#8364;541 million related to the remeasurement of expected future royalty of Beyfortus U.S. sales of which &#8364;414 million recorded in the fourth quarter primarily due to the product ramping up faster than initially expected.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">A &#8364;1,097 million tax effect arising from the items listed above, mainly comprising &#8364;567 million of deferred taxes generated by amortization and impairments of intangible assets and</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8364;397 </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">million associated with restructuring costs and similar items (see Appendix 4). </font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">A &#8364;365 million of deferred tax related to investments in subsidiaries in connection with the proposed separation of the Consumer Healthcare business at the earliest in Q4 2024.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">A loss of &#8364;231 million corresponding to an impairment on the stake in EuroAPI following the share price drop in the fourth quarter. </font></div><div style="margin-top:3pt;text-align:justify"><font><br></font></div><div><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Capital Allocation</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2023, free cash flow before restructuring, acquisitions and disposals increased by 10.4% to &#8364;9,830 million, after net changes in working capital </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(&#8364;478 milli</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">on) and capital expenditures (-&#8364;1,771 million). After acquisitions</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (-&#8364;1,113 million</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, proceeds from disposals</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8364;997 million) and payments related to restructuring and similar items (-&#8364;1,236 million), </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">free cash flow</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> is stable at &#8364;8,478 million. After the acquisition of Provention Bio (-&#8364;2,580 million), the acquisition of Qunol (-&#8364;1,335 million) and the dividend paid by Sanofi (-&#8364;4,454 million), net debt increased from &#8364;6,437 million on December 31, 2022 to &#8364;7,793 million on December 31, 2023 (amount </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">net of &#8364;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8,710 </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">milli</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">on cash and cash equivalents).</font></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-top:6pt;padding-left:180pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">--------</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Board of Directors of Sanofi, chaired by Chairman Fr&#233;d&#233;ric Oud&#233;a, met on January 31, to approve the fourth quarter and full year 2023 financial statements. </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This press release presents the results for the fourth quarter and the full-year 2023 from the consolidated financial statements of Sanofi as of December 31, 2023 (unaudited). The audit procedures by the Statutory Auditors are underway. </font></div><div style="margin-top:6pt;padding-left:180pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">--------</font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Not exceeding &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> N</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">on-IFRS financial measure (definition in Appendix 9).</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  12                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify;text-indent:216pt"><font><br></font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_46"></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Forward-Looking Statements</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:112%">This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, business transformations, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words &#8220;expects&#8221;, &#8220;anticipates&#8221;, &#8220;believes&#8221;, &#8220;intends&#8221;, &#8220;estimates&#8221;, &#8220;plans&#8221;, &#8220;potential&#8221;, &#8220;outlook&#8221;, &#8220;guidance&#8221; and similar expressions. Although Sanofi&#8217;s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the fact that product candidates if approved may not be commercially successful, the future approval and commercial success of therapeutic alternatives, Sanofi&#8217;s ability to benefit from external growth opportunities, to complete capital markets or other transactions and&#47;or obtain regulatory clearances, risks associated with developing standalone businesses, risks associated with intellectual property and any related pending or future litigation and the ultimate outcome of such litigation,&#8239; trends in exchange rates and prevailing interest rates, volatile economic and capital market conditions, cost containment initiatives and subsequent changes thereto, and the impact that pandemics, political disruption or armed conflicts or other global crises may have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under &#8220;Risk Factors&#8221; and &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; in Sanofi&#8217;s annual report on Form 20-F for the year ended December 31, 2022. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements. </font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:112%">All trademarks mentioned in this document are protected.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font><br></font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_49"></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Appendices</font></div><div><font><br></font></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:12.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i46d0ead8d5c7481bac049465b79fb3e4_52" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Appendix&#160;1&#58;</a>&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth-quarter and full-year 2023<a href="#i46d0ead8d5c7481bac049465b79fb3e4_52" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none"> sales by GBU, franchise, geographic region and product</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i46d0ead8d5c7481bac049465b79fb3e4_58" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Appendix 2&#58;</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth-quarter<a href="#i46d0ead8d5c7481bac049465b79fb3e4_58" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none"> and </a>full-year<a href="#i46d0ead8d5c7481bac049465b79fb3e4_58" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none"> 2023 business net income statement</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i46d0ead8d5c7481bac049465b79fb3e4_64" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Appendix 3&#58;</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth-quarter and full-year <a href="#i46d0ead8d5c7481bac049465b79fb3e4_64" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">2023 consolidated income statement</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i46d0ead8d5c7481bac049465b79fb3e4_67" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Appendix 4&#58;</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i46d0ead8d5c7481bac049465b79fb3e4_67" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Reconciliation of IFRS net income reported to business net income</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:174%"><a href="#i46d0ead8d5c7481bac049465b79fb3e4_70" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:174%;text-decoration:none">Appendix 5&#58;</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:174%"><a href="#i46d0ead8d5c7481bac049465b79fb3e4_70" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:174%;text-decoration:none">Change in net debt</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appendix 6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Simplified consolidated balance sheet</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appendix 7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current operating income net of expenses &#8211; Regeneron Alliances</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appendix 8&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency sensitivity</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i46d0ead8d5c7481bac049465b79fb3e4_82" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Appendix 9</a>&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i46d0ead8d5c7481bac049465b79fb3e4_82" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Definitions of non-IFRS financial indicators</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appendix 10&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CSR Dashboards</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt"><font><br></font></div><div style="text-align:justify"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Media Relations</font></div><div style="margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Sandrine Guendoul </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 25 09 14 25 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">sandrine.guendoul&#64;sanofi.com</font></div><div style="margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Nicolas Obrist </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 77 21 27 55 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">nicolas.obrist&#64;sanofi.com</font></div><div style="margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Victor Rouault </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 70 93 71 40 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">victor.rouault&#64;sanofi.com</font></div><div style="margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Sally Bain </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 1 617 834 6026 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">sally.bain&#64;sanofi.com</font></div><div style="margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Evan Berland</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%"> &#124; +1 215 432 0234 &#124; </font><font style="color:#5400b8;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">evan.berland&#64;sanofi.com</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Investor Relations</font></div><div style="margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Eva Schaefer-Jansen </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 7 86 80 56 39 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">eva.schaefer-jansen&#64;sanofi.com </font></div><div style="margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Arnaud Del&#233;pine </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 73 69 36 93 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">arnaud.delepine&#64;sanofi.com </font></div><div style="margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Corentine Driancourt </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 40 56 92 21 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">corentine.driancourt&#64;sanofi.com  </font></div><div style="margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Felix Lauscher </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 1 908 612 7239 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">felix.lauscher&#64;sanofi.com </font></div><div style="margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Nathalie Pham </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 7 85 93 30 17 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">nathalie.pham&#64;sanofi.com</font></div><div style="margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Tarik Elgoutni </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 1 617 710 3587 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Tarik.Elgoutni&#64;sanofi.com </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  13                   </font></div></div></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_52"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 1&#58; 2023 fourth-quarter net sales by GBU, franchise, geographic region and product</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:21.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.289%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2023 (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Sales</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% reported</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rest of the world</font></td><td colspan="3" style="background-color:#23004c;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Dupixent</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,990</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+31.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+24.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,299</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+28.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">329</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+32.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">362</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+52.5&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aubagio</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">121</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-74.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-75.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">43</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-87.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">70</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-43.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">8</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Myozyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">160</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-25.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">58</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-15.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">77</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-23.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-22.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Fabrazyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">242</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+0.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">129</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">53</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.6&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cerezyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">134</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-15.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">48</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">54</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">32</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.1&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Eloctate</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">103</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-21.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-25.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">69</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-23.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">34</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.6&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Alprolix</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">142</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+0.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">111</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">31</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-15.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Nexviazyme&#47;Nexviadzyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">131</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+115.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+101.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">76</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+63.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">35</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+337.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">20</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+212.5&#160;</font></td><td style="border-right:2pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Jevtana</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">77</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">55</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-71.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">20</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sarclisa</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">103</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+30.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+19.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">45</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+34.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">28</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">30</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+50.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Kevzara</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">105</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+41.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+32.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">61</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+45.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">31</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+24.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">13</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+70.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cerdelga</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">75</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">42</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">30</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+100.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aldurazyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">62</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">21</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">24</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cablivi</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">58</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">28</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-19.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+50.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Fasturtec</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">40</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">26</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Enjaymo</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">23</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+109.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+109.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">13</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+85.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">9</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+125.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Xenpozyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">26</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+58.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+52.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+350.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">6</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-50.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+200.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Alltuviio</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">94</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">92</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Others</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">28</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">6</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+20.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-33.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.5&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Specialty Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,714</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+13.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+6.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,235</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+12.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">783</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+4.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">696</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+28.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Toujeo</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">278</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">47</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-27.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">109</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">122</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+47.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lovenox</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">263</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-9.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-66.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">150</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">112</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.5&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Plavix</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">254</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">24</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">228</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.6&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Thymoglobulin</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">112</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">70</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">9</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">33</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+24.2&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Multaq</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">87</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-16.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">78</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">6</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Praluent</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+26.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+22.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">80</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+24.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">38</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+29.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Rezurock</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">86</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+44.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+36.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+38.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-300.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Mozobil</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">33</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-50.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-52.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">8</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-80.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">8</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Soliqua&#47;iGlarLixi</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">61</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+18.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">28</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">9</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+42.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">24</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+38.9&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Others core assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">284</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">35</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-40.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">98</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">151</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+29.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Core Assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,576</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+6.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-1.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">352</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-15.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">501</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+4.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">723</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+22.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lantus</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">277</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-24.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-35.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">34</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-68.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">160</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aprovel</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">106</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">20</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">84</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Others non-core assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">869</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-16.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">77</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-26.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">238</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">554</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.2&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Core Assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,252</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-11.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-20.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">113</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-47.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">341</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-13.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">798</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-2.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Industrial Sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">176</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+1.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-0.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">167</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-1.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+100.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;General Medicines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,004</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-2.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-10.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">467</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-26.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,009</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-3.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,528</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+8.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Influenza vaccines</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">741</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">224</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-40.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">258</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">259</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+80.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Polio&#47;Pertussis&#47;Hib vaccines </font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">434</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">91</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+20.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">66</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-18.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">277</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.9&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Meningitis, Travel and endemic vaccines</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">242</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">114</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+46.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">44</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+51.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">84</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-24.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Booster vaccines </font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">139</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">72</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">44</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">23</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-25.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Beyfortus</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">410</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">315</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">95</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,986</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+21.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+15.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">833</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+34.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">506</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+8.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">647</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+15.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Biopharma</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,704</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+9.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+2.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,535</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+10.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,298</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+1.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,871</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+14.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Allergy</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">147</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">71</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-16.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">8</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+28.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">68</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.9&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cough and Cold</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">125</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">65</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Pain Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">275</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">135</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">94</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Digestive Wellness</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">322</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+18.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">35</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">114</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">173</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+43.9&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Physical and Mental Wellness</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">182</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+58.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+45.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">84</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+521.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">26</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">72</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Personal Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">138</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">103</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-13.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">35</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+23.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Non-Core &#47; Others</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-31.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-39.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-133.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-76.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">19</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-32.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consumer Healthcare</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,215</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+8.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-2.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">341</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+10.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">353</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-5.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">521</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+17.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,919</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+9.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+1.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,876</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+10.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,651</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+0.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,392</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+14.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font><br></font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_55"></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  14                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font><br></font></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%"> 2023 net sales by GBU, franchise, geographic region and product</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.164%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Full year 2023<br>(&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Sales</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% reported</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rest of the world</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Dupixent</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10,715</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+34.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+29.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">8,145</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+32.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,224</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+30.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,346</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+46.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aubagio</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">955</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-52.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-53.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">460</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-67.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">437</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">58</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-33.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Myozyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">783</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-15.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-18.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">254</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-17.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">341</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-16.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">188</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-9.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Fabrazyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">991</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">503</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">241</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">247</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+18.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cerezyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">687</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">189</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+0.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">229</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">269</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+25.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Eloctate</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">471</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-15.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-18.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">341</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-22.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">130</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Alprolix</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">540</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">440</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">100</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Nexviazyme&#47;Nexviadzyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">425</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+126.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+116.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">272</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+77.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">100</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+494.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">53</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+190.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Jevtana</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">320</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-18.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">230</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-63.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">78</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sarclisa</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">381</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+37.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+29.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">165</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+33.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">111</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+27.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">105</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+53.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Kevzara</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">357</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">195</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">115</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">47</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+17.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cerdelga</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">298</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">164</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">16</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+23.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aldurazyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">279</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">67</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">82</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">130</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+23.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cablivi</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">227</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">112</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">98</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+171.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Fasturtec</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">170</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">110</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">43</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Enjaymo</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">72</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+240.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+227.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">42</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+152.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">6</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">24</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+420.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Xenpozyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">91</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+347.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+333.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">52</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+980.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">31</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+106.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">8</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+800.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Alltuviio</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">159</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">155</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Others</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">119</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-46.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-50.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">21</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-32.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-80.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">80</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-23.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18,040</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+14.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+9.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11,917</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+13.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,206</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+6.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,917</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+26.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Toujeo</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,123</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+0.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">213</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-23.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">441</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">469</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+26.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lovenox</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,125</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-58.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">622</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">496</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Plavix</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">948</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">8</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">96</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">844</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Thymoglobulin</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">478</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">292</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">37</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">149</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+19.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Multaq</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">344</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">310</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-25.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">22</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Praluent</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">422</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-101.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">296</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+30.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">127</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+46.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Rezurock</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">310</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+54.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+49.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">303</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+51.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+400.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Mozobil</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">220</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-15.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">119</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-22.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">70</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">31</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Soliqua&#47;iGlarLixi</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">217</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+0.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">95</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-18.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">35</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+24.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">87</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+40.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Others core assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,083</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">139</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-25.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">374</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">570</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Core Assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,270</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+3.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-1.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,485</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-7.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,988</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+4.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,797</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+9.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lantus</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,420</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-32.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-37.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">281</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-62.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">357</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-15.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">782</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-17.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aprovel</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">417</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">9</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+28.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">78</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">330</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Others non-core assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,687</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-9.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-15.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">302</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-24.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">961</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,424</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Core Assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,524</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-16.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-22.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">592</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-48.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,396</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-14.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,536</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-8.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Industrial Sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">582</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-5.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-6.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-58.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">548</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-6.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">27</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+75.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">General Medicines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,376</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-7.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-12.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,084</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-24.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,932</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-4.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,360</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-1.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Influenza vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,669</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,406</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">694</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">569</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Polio&#47;Pertussis&#47;Hib vaccines </font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,165</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">398</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">297</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,470</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Meningitis, Travel and endemic vaccines</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,170</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+0.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">650</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">154</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+41.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">366</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Booster vaccines </font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">598</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">323</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">180</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+16.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">95</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Beyfortus</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">547</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">407</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">140</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,474</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+8.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+3.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,264</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+4.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,697</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+26.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,513</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+3.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Biopharma</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,890</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+5.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+0.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17,265</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+5.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,835</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+4.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11,790</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+5.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Allergy</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">769</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">412</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">70</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+29.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">287</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cough and Cold</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">512</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">300</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">212</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Pain Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,106</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+0.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">180</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">502</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">424</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Digestive Wellness</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,502</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">138</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">520</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">844</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+23.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Physical and Mental Wellness</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">606</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+139.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">126</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">362</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Personal Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">550</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">409</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">140</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Non-Core &#47; Others</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">132</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-24.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-32.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(10)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">35</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-46.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">107</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consumer Healthcare</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,180</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+6.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-0.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,247</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-0.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,557</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+3.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,376</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+11.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43,070</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+5.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+0.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,512</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+4.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,392</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+4.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,166</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+6.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  15                   </font></div></div></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_58"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Appendix 2&#58; Business net income statement</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.860%"><tr><td style="width:1.0%"></td><td style="width:17.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.687%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fourth quarter 2023</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biopharma</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consumer Healthcare</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Other</font></div></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Group</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Q4 2023</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Q4 2022 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(a)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Q4 2023</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Q4 2022 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(a)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Q4 2023</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Q4 2022 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(a)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Q4 2023</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Q4 2022 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(a)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">9,704</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">9,483</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">2.3%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,215</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,242</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-2.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">10,919</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">10,725</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">1.8%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,268</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">715</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">77.3%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">14</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">16</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">-12.5%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#8212;%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,282</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">731</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">75.4%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of Sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3,550)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3,250)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">9.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(482)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(491)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">-1.8%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">-128.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(4,034)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3,734)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">8.0%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(36.6%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(34.3%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(39.7%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(39.5%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(36.9%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(34.8%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Profit</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">7,422</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">6,948</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">6.8%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">747</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">767</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-2.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(2)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">7</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-128.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">8,167</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">7,722</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">5.8%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">76.5%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">73.3%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">61.5%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">61.8%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">74.8%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">72.0%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,816)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,762)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">3.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(56)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(61)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">-8.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#8212;%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,872)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,823)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">2.7%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(18.7%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(18.6%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(4.6%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(4.9%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(17.1%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(17.0%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,460)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,444)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">0.7%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(473)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(448)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">5.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">-166.7%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,931)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,895)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">1.2%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(25.4%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(25.8%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(38.9%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(36.1%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(26.8%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(27.0%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current operating income&#47;expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(905)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(395)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">84</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">38</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">81</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(821)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(276)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit&#47;loss of associates* and joint ventures</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">42</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">47</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">6</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non controlling interests</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(4)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(6)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(4)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(7)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(10)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business operating income</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,279</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,344</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-2.8%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">304</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">295</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">3.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">85</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-100.0%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,583</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,724</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-5.2%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">23.5%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">24.7%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">25.0%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">23.8%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">23.7%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">25.4%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income and expenses</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(49)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(28)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expenses</font></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(451)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(555)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Tax rate**</font></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(18.1%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(20.6%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="9" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,083</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,141</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-2.7%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">19.1%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">20.0%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business earnings &#47; share(in euros)***</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1.66</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1.71</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-2.9%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt"><font><br></font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">* Net of tax.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">** Determined on the basis of Business income before tax, associates, and non-controlling interests.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">*** Based on an average number of shares outstanding of 1,253.6 million in the fourth quarter of 2023 and 1,254.0 million in the fourth quarter of 2022.</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-weight:400;line-height:112%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:112%"> 2022 figures have been adjusted to take account of the two new operating segments, Biopharma and Consumer Healthcare, effective from January 1, 2023.</font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  16                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="text-indent:8.99pt"><font><br></font></div><div><font><br></font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_61"></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:4.49pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:4.49pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.834%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Full Year 2023</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biopharma</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consumer Healthcare</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Other</font></div></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Group</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FY 2022 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(a)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FY 2022 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(a)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FY 2022 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(a)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FY 2022 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(a)</font></div></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">37,890</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">37,812</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">0.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">5,180</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">5,185</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-0.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">43,070</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">42,997</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">0.2%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,322</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,330</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">42.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">52</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">62</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">-16.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#8212;%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,374</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,392</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">41.1%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of Sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(12,282)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(11,793)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">4.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,933)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,903)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">1.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">-125.0%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(14,216)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(13,692)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">3.8%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(32.4%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(31.2%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(37.3%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(36.7%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(33.0%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(31.8%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Profit</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">28,930</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">28,349</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">2.0%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">3,299</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">3,344</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-1.3%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(1)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">4</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-125.0%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">32,228</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">31,697</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">1.7%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">76.4%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">75.0%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">63.7%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">64.5%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">74.8%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">73.7%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(6,509)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(6,503)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">0.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(219)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(205)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">6.8%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">-100.0%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(6,728)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(6,706)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">0.3%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(17.2%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(17.2%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(4.2%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(4.0%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(15.6%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(15.6%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(8,868)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(8,736)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">1.5%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,828)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,761)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">3.8%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">-20.0%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(10,692)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(10,492)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">1.9%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(23.4%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(23.1%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(35.3%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(34.0%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(24.8%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(24.4%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current operating income&#47;expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,387)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,679)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">181</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">148</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(18)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,224)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,514)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit&#47;loss of associates* and joint ventures </font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">101</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">76</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">21</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">122</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">88</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non controlling interests</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(20)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(17)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(16)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(16)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(36)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(33)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> </font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">11,247</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">11,490</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-2.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,438</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,522</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-5.5%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(15)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">28</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-153.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">12,670</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">13,040</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-2.8%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">29.7%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">30.4%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">27.8%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">29.4%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">29.4%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">30.3%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income and expenses</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(181)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(234)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expenses</font></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,334)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,465)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Tax rate**</font></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(18.8%)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(19.3%)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="9" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">10,155</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">10,341</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-1.8%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">23.6%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">24.1%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business earnings &#47; share(in euros)***</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">8.11</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">8.26</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-1.8%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-indent:4.49pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:1pt;text-indent:4.49pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">    </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">    * Net of tax.&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">** Determined on the basis of Business income before tax, associates, and non-controlling interests.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">*** Based on an average number of shares outstanding of 1,251.7 million in the full year of 2023 and 1,251.9 million in the full year of 2022.</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-weight:400;line-height:112%;position:relative;top:-2.44pt;vertical-align:baseline">(a)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:112%"> 2022 figures have been adjusted to take account of the two new operating segments, Biopharma and Consumer Healthcare, effective from January 1, 2023.</font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  17                   </font></div></div></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_64"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 3&#58; Consolidated income statements</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:54.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.074%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q4 2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FY 2022</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,919</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,725</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">43,070</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">42,997</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,282&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">731&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,374&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,392&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,048)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,734)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,236)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,695)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross profit</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,153</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,722</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">32,208</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">31,694</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,872)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,823)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,728)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,706)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling and general expenses</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,931)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,895)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,692)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,492)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">344&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,292&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,969&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating expenses</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,108)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(524)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,516)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,531)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(575)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(457)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,172)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,053)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Impairment of intangible assets</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(877)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,127&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(896)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">454&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring costs and similar items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(684)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(170)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,490)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,336)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other gains and losses, and litigation</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(233)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">342</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,103</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,875</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,656</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial expenses</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(625)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(148)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,313)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(440)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income before tax and associates and joint ventures</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(121)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,075</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,153</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,422</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(309)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(910)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,602)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,006)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of profit&#47;(loss) of associates and joint ventures</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(128)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(115)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(558)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,168</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,436</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,484</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income attributable to equity holders of Sanofi</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(555)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,111</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,400</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,371</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average number of shares outstanding (million)</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,253.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,254.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,251.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,251.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IFRS Earnings per share (in euros)</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.44)</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.48</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.31</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6.69</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  18                   </font></div></div></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_67"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 4&#58; Reconciliation of Net income attributable to equity holders of Sanofi to Business net income</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:52.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.933%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q4 2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FY 2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FY 2022</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income attributable to equity holders of Sanofi</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(555)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,111</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,400</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,371</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization of intangible assets </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">575&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">457&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,172&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,053&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Impairment of intangible assets </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">877&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,127)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">896&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(454)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expenses arising from the impact of acquisitions on inventories</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income resulting from license-out</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(952)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring costs and similar items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">684&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,490&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,336&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other gains and losses, and litigation </font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">233&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Financial (income) &#47; expense related to liabilities carried at amortized cost other than net indebtedness</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">541&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of the items listed above&#58;</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(507)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">355&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,097)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(459)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Amortization and impairment of intangible assets</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(240)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">419&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(567)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(267)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(5)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(13)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Expenses arising from the impact of acquisitions on inventories</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Restructuring costs and similar items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(167)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(30)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(397)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(231)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Other items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(92)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(36)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(117)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">48&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other tax effects </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">365&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">365&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,083</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,141</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,155</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,341</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">IFRS earnings per share </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4) </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in euros)</font></div></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.44)</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.48</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.31</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6.69</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:112%">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:112%;padding-left:7.21pt">Of which related to amortization expense generated by the intangible assets measured at their acquisition-date fair values&#58; &#8364;559 million in the fourth quarter of 2023 and &#8364;443 million in the fourth quarter of 2022.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:112%">(2)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:112%;padding-left:7.21pt">For 2023, this amount mainly comprises an impairment loss of &#8364;833 million, reflecting the impact of the strategic decision to de-prioritize certain R&#38;D programs, in particular those related to the NK Cell and PRO-XTEN</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-2.44pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:112%"> technology platforms.</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">In 2023, deferred tax related to investments in subsidiaries in connection with the proposed separation of the Consumer Healthcare business at the earliest in Q4 2024.</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:5.66pt">Q4&#58; Based on an average number of shares outstanding of 1,253.6 million in the fourth quarter of 2023 and 1,254.0 million in the fourth quarter of 2022.</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;FY&#58; based on an average number of shares outstanding of 1,251.7 million in the full year of 2023 and 1,251.9 million in the full year of 2022.</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="margin-top:3pt;text-indent:36pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  19                   </font></div></div></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_70"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 5&#58; Change in net debt</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.766%"><tr><td style="width:1.0%"></td><td style="width:70.039%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FY 2022</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,155</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,341</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation &#38; amortization &#38; impairment of property, plant and equipment and software</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,589&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,587&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(621)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(955)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating cash flow</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11,123</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,973</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in Working Capital</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">478&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(477)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions of property, plant and equipment and software</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,771)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,594)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Free cash flow before restructuring, acquisitions and disposals</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,830</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,902</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisitions of intangibles assets, investments and other long-term financial assets </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,113)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(824)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring costs and similar items paid</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,236)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,126)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets net of taxes</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#160;(1)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">997&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,531&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Free cash flow</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,478</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,483</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisitions of investments in consolidated undertakings including</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">assumed debt </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,484)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,192)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from disposals of assets net of taxes </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of Sanofi shares</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition of treasury shares</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(593)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(497)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid to shareholders of Sanofi</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,454)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,168)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(498)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">631&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in net debt</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1,356)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,546</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;border-top:2pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of period</font></td><td colspan="2" style="background-color:#f4f2f6;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,437</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,983</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Closing of net debt</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,793</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,437</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">Free cash flow includes investments and divestments not exceeding a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">Includes transactions that are above a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  20                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_73"></div><div><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 6&#58; Simplified consolidated balance sheet</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.022%"><tr><td style="width:1.0%"></td><td style="width:22.831%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.831%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Assets (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">December 31, 2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">December 31, 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Liabilities &#38; equity  (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">December 31, 2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">December 31, 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Equity attributable to equity holders of Sanofi</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">74,040</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">74,784</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Equity attributable to non-controlling interests</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">313</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">368</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Total equity</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">74,353</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">75,152</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Long-term debt</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">14,347</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">14,857</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Property, plant and equipment - Owned Assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">10,160</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">9,869</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Non-current lease liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">1,755</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">1,904</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Right-of-use assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">1,654</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">1,815</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Non-current liabilities related to business combinations and to non-controlling interests</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">501</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">674</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Intangible assets (including goodwill)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">73,573</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">71,532</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Non-current provisions and other non-current liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">7,639</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">6,341</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Non-current income tax assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">188</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">242</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Non-current income tax liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">1,842</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">1,979</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Non-current financial assets &#38; investments in associates and deferred tax assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">10,069</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">9,153</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Deferred tax liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">1,857</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">1,841</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Non-current assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">95,644</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">92,611</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Non-current liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">27,941</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">27,596</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Accounts payable &#38; Other current liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">20,882</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">18,834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Current liabilities related to business combinations and to non-controlling interests</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">208</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">105</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Inventories, accounts receivable and other current assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">21,554</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">20,916</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Current income tax liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">597</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">574</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Current income tax assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">391</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">374</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Current lease liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">275</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">277</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Cash and cash equivalents</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">8,710</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">12,736</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Short-term debt and current portion of long-term debt</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">2,045</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">4,174</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Current assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">30,655</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">34,026</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Current liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">24,007</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">23,964</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Assets held for sale or exchange</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">15</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">85</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Liabilities related to assets held for sale or exchange</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">13</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">10</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Total assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;text-indent:13.5pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">126,314</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;text-indent:13.5pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">126,722</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Total equity and liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">126,314</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;text-indent:13.5pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">126,722</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  21                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_76"></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 7&#58; Other current operating income net of expenses related to Regeneron </font></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.318%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">&#8364; million</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">FY 2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">FY 2022</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Monoclonal </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Antibodies Alliance</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Income &#38; Expense related to profit&#47;loss sharing</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:83%">(3,321)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(2,325)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Additional share of profit paid by Regeneron related to development costs</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:83%">668</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:10pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:115%">434</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Regeneron commercial operating expenses reimbursement</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:83%">(543)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:10pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(476)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total&#58; Monoclonal Antibody Alliance</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:83%">(3,196)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:10pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(2,367)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Immuno-Oncology Alliance</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total Immuno-Oncology Alliance</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:83%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:115%">16</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Other Regeneron</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total others related to Regeneron (mainly Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:115%">and Zaltrap</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:115%">) </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:83%">217</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">168</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total related to Regeneron</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2,979)</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:1pt solid #525ca3;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2,183)</font></td></tr></table></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:112%">(1) In 2022, this line excludes an upfront payment of $900 million and a regulatory milestone payment of $100 million received by Sanofi from Regeneron in connection with the Amended IO Discovery Agreement signed in June 2022. These items are included in the Consolidated income statements line Other Operating Income.</font></div><div><font><br></font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_79"></div><div style="margin-bottom:6pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 8&#58; Currency sensitivity</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 business EPS currency sensitivity</font></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Currency</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Variation</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business EPS Sensitivity</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Dollar</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+0.05 USD&#47;EUR</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;-EUR 0.17</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japanese Yen</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+5 JPY&#47;EUR</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-EUR 0.02</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chinese Yuan</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+0.2 CNY&#47;EUR</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;-EUR 0.02</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazilian Real</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+0.4 BRL&#47;EUR</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;-EUR 0.01</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Russian Ruble</font></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+10 RUB&#47;EUR</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;-EUR 0.01</font></div></td></tr></table></div><div style="margin-top:4pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:87%">Currency exposure on Q4 2023 sales</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:87%"> </font></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Currency</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q4 2023</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US $</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Euro &#8364;</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chinese Yuan</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japanese Yen</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexican pesos</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazilian Real</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canadian $</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australian $</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">British Pound</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Korean won</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Others</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-top:4pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:80%">Currency average rates </font></div><div style="margin-bottom:4pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q4 2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;&#47;$</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.021&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.076&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">+5.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;&#47;Yen</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144.203&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.030&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">+10.3%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;&#47;Yuan</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.264&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.778&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">+7.1%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;&#47;Real</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.372&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.329&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">-0.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;&#47;Ruble</font></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.072&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.644&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">+55.5%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:4pt;margin-top:6pt"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  22                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:4pt;margin-top:6pt"><font><br></font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_82"></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 9&#58; Definitions of non-IFRS financial indicators</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Company sales at constant exchange rates (CER)</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we refer to changes in our net sales &#8220;at constant exchange rates&#8221; (CER), this means that we exclude the effect of changes in exchange rates.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We eliminate the effect of exchange rates by recalculating net sales for the relevant period at the exchange rates used for the previous period.</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reconciliation of net sales to Company sales at constant exchange rates for the fourth quarter and the full-year 2023.</font></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q4 2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,919</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">43,070</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rates</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(799)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,189)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company sales at constant exchange rates</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11,718</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">45,259</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:7pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Business net income</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi publishes a key non-IFRS indicator. Business net income is defined as net income attributable to equity holders of Sanofi excluding&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">amortization of intangible assets,</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">impairment of intangible assets, </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">fair value remeasurement of contingent consideration related to business combinations or to disposals,</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">expenses arising from the impact of acquisitions on inventories</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">restructuring costs and similar items</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">other gains and losses (including gains and losses on disposals of non-current assets</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">),</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">costs or provisions associated with litigation</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">upfront payments and regulatory milestone payments recognized in the line item Other operating income and arising from transactions outside the scope of Sanofi's ordinary activities,</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">financial (income)&#47;expense related to liabilities carried at amortized cost other than net indebtedness, </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">tax effects related to the items listed above as well as effects of major tax disputes,</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">the share of profits&#47;losses from investments accounted for using the equity method, except for joint ventures and associates with which Sanofi has a strategic alliance,</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">net income attributable to non-controlling interests</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to the items listed above.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(1) Reported in the line items </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:120%">Restructuring costs</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:120%">and similar items</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:120%">Gains and losses on disposals, and litigation</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">, which are defined in Notes B.16. and B.17. to our consolidated financial statements.</font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Free cash flow </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Free cash flow is a non-IFRS financial indicator which is reviewed by our management, and which we believe provides useful information to measure the net cash generated from the Company&#8217;s operations that is available for strategic investments</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (net of divestments</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), for debt repayment, and for capital return to shareholders. Free Cash Flow is determined from the Business Net Income adjusted for depreciation, amortization and impairment, share of profit&#47;loss in associates and joint ventures net of dividends received, gains &#38; losses on disposals, net change in provisions including pensions and other post-employment benefits, deferred taxes, share-based expense and other non-cash items. It comprises net changes in working capital, capital expenditures and other asset acquisitions</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> net of disposal proceeds</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and payments related to restructuring and similar items. Free cash flow is not defined by IFRS and it is not a substitute measure for the IFRS aggregate net cash flows in operating activities.</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Amount of the transaction above a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Not exceeding a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  23                   </font></div></div></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_85"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reconciliation from net cash provided by&#47;(used in) operating activities to free cash flow</font></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.419%"><tr><td style="width:1.0%"></td><td style="width:74.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2023</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2022</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net cash provided by&#47;(used in) operating activities in the Consolidated statements of cash flows</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,258</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,526</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition of property, plant and equipment and software</font></td><td colspan="2" style="background-color:#f4f2f6;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,771)</font></td><td style="background-color:#f4f2f6;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,656)</font></td><td style="border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisitions of intangibles assets, investments and other long-term financial assets</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,113)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(824)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets net of taxes</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">997&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,531&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Repayment of lease liabilities</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(265)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(291)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Others</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(803)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Free cash flow</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,478</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,483</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Most directly comparable IFRS measure to free cash flow.</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Transactions up to &#8364;500 million per transaction.</font></div><div style="margin-bottom:6pt;margin-top:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Non IFRS indicator (see definition in Appendix 9).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"><br></font></div><div id="i46d0ead8d5c7481bac049465b79fb3e4_88"></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  24                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font><br></font></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Appendix 10&#58; CSR dashboards</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Data is presented in YTD unless stated otherwise.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:18.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.251%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.740%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Topic</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ambition</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Progress</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FY 2023</font></td><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FY 2022</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affordable access </font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi Global Health</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reach 1.5 million NCD patients by 2026 (cumulative since 2022) and 2 million by 2030<br></font><font style="font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br></font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,977 patients treated in 31 countries</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 active healthcare partnerships in 15 countries</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 investments signed through the Impact Fund</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,151 patients treated in 28 countries</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 active healthcare partnerships in 11 countries</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 investment signed through the Impact Fund</font></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vials donations</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donate 100,000 vials a year to treat people with rare diseases</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163 patients treated<br>124,136 vials donated</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122 patients treated<br>121,025 vials donated</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global Access Plans </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Develop a Global Access Plan for all new products to make them available within two years after first launch</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 Global Access Plans initiated or <br>developed covering more than 12 <br>indications</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 Global Access Plans initiated </font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&#38;D for unmet needs</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sleeping sickness</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Develop and supply innovative treatments to support the elimination of sleeping sickness by 2030</font></div><div><font><br></font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Data updated annually, next update in Q2 2024</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 million patients tested<br>837 patients treated</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Polio</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provide inactivated polio vaccines (IPV) to UNICEF for GAVI countries to support polio eradication efforts</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35  million IPV doses supplied to UNICEF for GAVI countries</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 million IPV doses supplied to UNICEF for GAVI countries</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pediatric cancer treatment development</font></div><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Develop innovative treatments to eliminate cancer death in children</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 assets undergoing pre-clinical assessment</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First pediatric patient dosed with 1 clinical asset in a clinical study (less than 2 years after the 1st adult patient was dosed with this compound)</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 asset pre-clinical assessment complete<br></font><font style="font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 asset in protocol preparation for clinical study<br></font><font style="font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 additional asset identified for clinical development </font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Planet Care</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Climate change - Carbon footprint </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(CO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">emissions)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55% reduction in scope 1&#38;2 greenhouse gas emissions (CO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> equivalent) by 2030 (cumulative vs 2019 baseline) to contribute to carbon neutrality by 2030 and net zero emissions by 2045 (all scopes)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38% GHG reduction vs 2019</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29% GHG reduction vs 2019</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renewable electricity</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% of renewable electricity in all our sites by 2030<br></font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79%</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eco-car fleet</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% eco-car fleet in 2030</font></div><div><font><br></font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43% eco-car fleet </font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34% eco-car fleet</font></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blister free syringe vaccines</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% blister free syringe vaccines by 2027</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39% blister free syringe vaccines</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33% blister free syringe vaccines</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eco-design</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All new products to be eco-designed by 2025<br></font><font style="font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br></font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 LCAs completed &#38; 2 in progress (new and <br>marketed products)</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 LCAs completed &#38; 1 in progress (new and <br>marketed products)<br>Eco design digital solution launched</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In and beyond the workplace<br></font></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  25                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:18.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.251%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.740%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global Gender balance</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ambition of 50% of women in senior leadership roles by 2025</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44%</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42%</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:0.5pt solid #21004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ambition of 40% of women in executive roles by 2025</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40%</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Engagement with communities</font></div><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Engage socially and economically with all communities where we operate<br></font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,240 volunteers<br> 75,376 hours</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,825 volunteers<br>46,976 hours</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">From Leaders to Citizens</font></div><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% of Sanofi leaders have CSR in their development path</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71% of the leaders have completed the eLearning phase<br><br>30% of the leaders have completed the full program</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#62;50% of the leaders have completed the eLearning phase</font></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  26                   </font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>capturedecran2024-01x23a18a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 capturedecran2024-01x23a18a.jpg
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MJH)JH8:H)3H:9:!,-!2-12>AZ>@TM  M0I>A%6@-N@MM0$^B%]'K:!?Z AW
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MOJ;FI()_8_(]YP]Y_WP&4E5G\//Y7RGV?'YJNB_3    BF58269-30 J
M"  $ 1H !0    $    ^ 1L !0    $   !& 2@  P    $  @  AVD !
M  $   !.         )     !    D     $  Y*&  <    2    >* "  0
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MD("F/B "(B "(B "(B "(B "(B "(B "(B "(B "ZR$@ 6T]<+1*!$1 !$1
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M)P]2IYA+H EY73:+DWA6ATU[_;IF0046_UKNK!8]L?5%T?;:;K5+!$1 !$1
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M;I\%S++Y^ DAR\::[K=VPN%LG>L2X1P4O8B "(B "(B "(B "(B "(B "(B
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MPFNI\VNH'7:L<.RWI,QH7/-=3[HJ2C1JJ6N@>D5 !$1 !$1 !$1 !$1 !$1
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M(89Z792'@>#H6MJ362@MV4&_'6HG16AL_=I>!$1 !$1 !$1 !$1 !$1 !$1
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MB!@"$M BYE*IH2(@ B(@ B(@ B(@ B(@ B(@ B(@ B(@ FU!0 ):6U#7,45
M!$1 !$1 !$1 !$1 !$1 !$1 !$1 !"*&@ 2TB+E4:J@(B( (B( (B( (B( (
MB( (B( (B( (B$!;$)" UA;4=4P1$ $1$ $1$ $1$ $1$ $1$ $1$ $1$(&(
M(2 !+6(NE1HJ B(@ B(@ B(@ B(@ B(@ B(@ B(@ B+0%@0DH+4%=1U3!$1
M!$1 !$1 !$1 !$1 !$1 !$1 !$0@8@A(0(N82Z6&BH (B( (B( (B( (B( (
MB( (B( (B( (M 4!"6AM05W'% $1$ $1$ $1$ $1$ $1$ $1$ $1$ $1B!@"
M$M BYE*IH2(@ B(@ B(@ B(@ B(@ B(@ B(@ B(@ FU!0 ):6U#7,45 !$1
M!$1 !$1 !$1 !$1 !$1 !$1 !"*&@ 2TB+E4:J@(B( (B( (B( (B( (B( (
MB( (B( (B$!;$)" UA;4=4P1$ $1$ $1$ $1$ $1$ $1$ $1$ $1$(&((2 !
M+6(NE1HJ B(@ B(@ B(@ B(@ B(@ B(@ B(@ B+0%@0DH+4%=1U3!$1 !$1
M!$1 !$1 !$1 !$1 !$1 !$0@8@A(0(N82Z6&BH (B( (B( (B( (B( (B( (
MB( (B( (M 4!"6AM05W'% $1$ $1$ $1$ $1$ $1$ $1$ $1$ $1B!@"$M B
MYE*IH2(@ B(@ B(@ B(@ B(@ B(@ B(@ B(@ FU!0 ):6U#7,45 !$1 !$1
M!$1 !$1 !$1 !$1 !$1 !"*&@ 2TB+E4:J@(B( (B( (B( (B( (B( (B( (
MB( (B$!;$)" UA;4=4P1$ $1$ $1$ $1$ $1$ $1$ $1$ $1$(&((2 !+6(N
ME1HJ B(@ B(@ B(@ B(@ B(@ B(@ B(@ B+0%@0DH+4%=1U3!$1 !$1 !$1
M!$1 !$1 !$1 !$1 !$0@8@A(0(N82Z6&BH (B( (B( (B( (B( (B( (B( (
MB( (M 4!"6AM05W'% $1$ $1$ $1$ $1$ $1$ $1$ $1$ $1B!@"$M BYE*I
MH2(@ B(@ B(@ B(@ B(@ B(@ B(@ B(@ FU!0 ):6U#7,45 !$1 !$1 !$1
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MH3/K^'VBHU_!YCT_]8?FY:G:UD]  MKZ^6AM(PCH0:@1L#:13=4GZE_H( ?
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M)[(RMD7/KCLB/G8@@A51M%D+'<,3G4#=CI^=&)?*X[(.KD44V]*.BPUPK$A
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MBF&T(O/Q]YNB6CDS:E90#,OJNA)Y>7Y:$2=S7UJ=\^;MI15:,3UF*FF($+)
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MT,)=*+97(I:3_.VBV,0EQU;1-O%DQD1UBO5S\Y)Q?9BNZRW9-^H<NEF^MIB
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M\J";]2V-2L#AU]Z*HJKLG34KJSG4"2^G<!7+ 6Y9=_3I]C/.W)UQ3#C@]5!
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M.%^<1:$;5/D?OSKQA]$VZ:K)) +//N9.:=$EX^#]]G..9F.0=L(I*'SV<2>
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M#+3S5]TX<7M(G;90 FJ6F#A$HSGD37'FWT_?H6Z:FV+6F7',*E8X-SJUK*C
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MHO0Q:_KW^'GS;Q2*-J.!H'E8<D__KLBP%<50B()Y<N&WPZMHWTJ*>&,TG;L
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MH<6Q[R9S7L+#8_E/>H48]C7RSXS.LY!07YA2:#PDA EJ",8<_F$#0W,EK%@
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MX*&+&#JX+_;M/T#=I0><?/JC>8/*%.EU1-%B>1FR=0I[#U]"7L;/+R$C04H
MVU*7+MTP??HT%;^^D.S!'(Q'7[UZE?+D^'-BU+-G;\SDY*1BQ0IJG_W[]V/+
MEI]A3]; BA7?J'5!08%HW[Z3JJ=FS1I8MNQK7+ER#5NW_H0??]R,7;MV8^W:
MU;C&D&(_/S\</'@0]>K5@YU=#F8)S$[P;!5^_GD+M9W\%1 G=;=HT5Q]#^.@
MV*E3)_3MVU^MJUJU"BY=NL3O?=2Q/^9/5K>)=YZ+&F<$0!/C*(8A=QT(-)AQ
M<BKKI(@G1[/TMK]Z?&=C:%SQ?QS8OQJY\S%S(1FDB\Z<QYYCI]4S$X-4 7&J
M+O[AMJ*QH=6WD+IU=47,UPR=&E]"6>,@Q-);25U@SN$(H D._BF*C+52-*?$
M"3/! 9YKX=QM4=B1C@RFO==C2(D C)J32)[LJYT^SQ\Q<*2XNKJJSX_]HS30
MR$"KTZPS$FBLBG<PA!DO0V@XN!0L@*%].V-0WY[J,#T&C,3!8V<4:&#*L"O)
MQAD9+0!X@S0::++^+#V.+=KVA $-(2?[G$Q,T!$].K5%#KY/F2DM._;A!/R&
MTCUKV[P!5BR<@1RVMIG9-<TV8E3MXM@S60 TCBU_%\(INF5^_E&"V>#$.2_V
M3_DXN3=1&F:1D7'(XT#0A@;Z@T?!\/:/)'!&S2)ZX4,(D/GSG2E5-#L]H&;4
M/HH@J!?+OLH4IF0[/'T>@MMW AFR8JHTT:S)5A/@+2O*I^PC0OZZ@^!+-V@G
M!,O;G^9TM7V!V,,R*4@BJ!K)R64<$X>D6*MI]LC@"_<3,J>%+IG+@L00Q)*B
M1^:B&64<;!K6A#[9'J_.G<7=]>N9P?.Q.@M#AKDYU*@)YRY=5)BEMN;09\_P
MC'WWT[U[E-Y8V0E?PK)0(6;/BX+?]>NX-FD20\JIET2PSIG.QF)]^JB^2(SJ
M>#I//$^<P.-=.PF4/58 L3#+;$N51J$V;>%4KZXZC/^=.WCXTT_P_O,"H[E-
MD)OAF:4G3(!9[MSJ]UB.!Z*Y=F4A938X?K$*6.;+CP+MV(^T:JT]U4_Z^3$3
MH5@^AV7K_E!9.)URVV+N> V )J&IVB+,K#].W\:$^4S4Q EFHYK%"0XU5%DW
MM=L(P/[0[14&?/D3GC A3>6R!=&;HONM&Y;3;I+F,R$Q5@%HI^^3#4*A]MI%
M%L'&W(5,(SJSXD+Q(O B+KHQ6H&@=-L*/Z''B%T$QQX1)+/#%^4+$10EPUV<
M/62YB&U2K6(ALD;U<?#X36S9^R?[,WOE '-_[H/2U"[3,M $>'M&/;)FO9=S
M0A6!Q5/:H6NKJHI5%D4 3<#"H5,W4^<L!LMG=E;M8NFZ(PAER.KH?@W0M4T5
MQ6(3 .V7_1=1D8[$::-:D!E'&S,5@-:?#+11?5,!:%[^M('"<?.R-_P\PV%$
MG3DK,E?MK,W0M)(#ZI7)A1QDOD@;S(KR,6TB*X[_UCJD(^'S2NDS>+WM1G5"
M0%(0;/2-"$;;P>Q&-$HSF]]?.L_@5*,4P3%F:&4R 4,BK4;QII0BH],G&W4,
MDXRHQQC/<,P(V% 1H&+Q7(@.?H7'GHD<KY@ME8!;DB2^(M"FHVO(T&^"W72L
M)/&8<03+!$P5EHH 9S(Y%P=J'",D9)P4%JPN'7L19+/%R+;A"2CI6!)+)B^$
MF:!Y_\*2F38A_;X :*VJ+\741:W1N$V9E"N=-7X/SAV^CR.WJ*><W$[EOM4I
M,1=M.U?!B.D-\?W71[%V\4D<O/0E'/)8INP;0R9W_=+ST:IS!8R9T40!:)?.
MN>'4[:GJ'==N&!H<B2:5OT*+3F4Q89;&(>[QE'.'+Y:2%=8135K*^23!YU4H
MFE9<A.&3&Z(G ;EWE6?N_NA:_UM\M:X+JM61>0N3P]#A5;OH'-1I48RLNO9I
M=I\R?#LN$,@[?I/1-^QD&I2>AVH-73#C*R&LO"X+)_Z*/;]<P>G[4].$<DKS
M_E\ T.1.W'CP&(.FSE<).)K7J8GF=:KC!IUK-2N5HU9@_M<WBTOI ;2YWV_@
M6.%!C30RT'IW1LNZ-=-L+U_2 VC;O^4SG[688O^2T"D65_9N)C-50RIZ8^?D
M%2<N7<6W/^VD!(=',H VCP!:6M:@;*H%T"3I5"F&>*Z?/Q6W'STA8SF("0\*
M*-OV;<?XU.L%8'O$$-,HVBW%B&=D8[30OZU\%@#M@VZ*#$KR3UD4'U3#?SM]
MYCN0U1.AMP%H21PH<M3_.PTT-R;6?)%R!\2$^^Z0/L[?-L':94-A8Y==>>:"
MPV/0K>]7F$X K3(U0L1X[3_R>V9.,4??WDTQ;.Q*]._>$,W),A/0E+&Z'&CC
ML>Z'W0SS>(2U7P_C!(H9TEA_]^$K4)'Q\2=.G"*HM9&3SQP9 FA&9+^5*E4*
MDR=/)-@E %HO!:!5JE11&3S=R3Z3W\^<.8,U!-H<\SB2R1:(=NTZ*@"M5JV:
M9)F%$/3J0G"N,XX=.X82)4IB_/BQZGH]/#PP<.!@S)\_#V7+EL'QX\<)H*W&
MMFV_8-Z\^7C&2=JF31M2[HTL7+ERE77/P+1I4_#%%U^D^>UCOF1UFWCGN<A#
M4*&)LJ"/EDT'XZF;-^U:F=2J'S6[2PBC0KTTDUW-2LU?3F'(Y(CE0!:*!8O&
MH6W[9F2J1.+L"S],6,]0<K+*).&$OAD-%H:G)\;:0,_$7TV8$F)H\2;1F&68
MA%&V4.@EQF"<ZVT"#0RE(/O1E(++"?H$;K-F/I'ZM#7+4B_;KW2;XDS6X81,
M,G)5I-Z.G55M_L@)ONC!J>.GNA]OUO3)UHC!*\7U$P!H\001&KE6XV30F+IB
M#^%-AT,EBL#N^G$5CI\^AWE?K\+-NP\HHO\%BKL4Q-J?MG&B\F82@01.G)^1
M&M^FRP!X>/NJ, DQ:.QLK*FI9(\">9G&O'A15&6FI@+4-9/C:8LPB:*I-56;
MC+@[#]QH%)BB9\<VF#MMO +0M=ME]O-] 30?OTC%(@LE("8,M)RV)BH$\^GS
M4 )P"7!T,*/^FJ%BL;A[A*ID 8$$W8H4LB+@G(N9HT0P78?>T2 RXF()N%FH
M=1%DK7EPDGSBC"=*DKE6LI@-Q=6-,GL9[]SN4_81"332_/\X __?CB'LH3O?
M &GW-"O85E+>?KXSC'>";8V*,"I1"/XOF=;^]&DR#;B%UOZ0Y0R*,+C,J#E6
M9>9L^*W;CN"[CQ##L D#ZAEE+^:,/*/Z4$4Q#L\/'L*3G3O((HR"@&?Y6K1
MOJ;-8)D_/_13L0D3:4#'$/R-HJ-#-,>,Z6P1/;*X\##X7K^!ZU.G*@#-A 9Z
MX;8: $U[6L)0CV>89A!!NJ<$X5Z</,D^BB'HW-_1M18JC&<;Y++?C>O44]L!
M'X)Z20P3M7-Q1CD"=69Y\JBJA*T7'QV%^S]MQHM3IQ'Q\H4"UR24LQSK^!PE
M,Q/CMYU'^B0"$L+I6K4(V[6@4Z_+ X)C/49O()/,![7YNX1,5B!XE+ZT'O ]
M+M]XPDR%CNC?I1;:-BZ??I.4[_[A]W#L[I=D><6@8L'!#.&LE1S"^1*/O0_C
MGM<.3JYUT*'R+^@Q<B>.G[VO,EPNFM2.[^6;(,:M^R^P=NOIE"R<WTSOA%&S
MMN'F?4^>LS/&#FC(,$\F) B+1I56\PF@A6)8#U?T[41I%&8@%7#PNQ]/,+OH
M*39E/7P]XW4(9TAH),;V;X1N;:HJ1OW$!3L)U%U$^9)Y,7-,2U0J30 M@,ZU
MX:O9GWJB;X?J&#NP(2RMS54(YS'JJETX[PD/@O&Q[%OL;<S0L+P]^C1D(@L"
M:5E=/J9-9/6YI*E/S54H[<!!5]CE L0L6+<8AZ\>A0E9J,:>YL@90L=%$5O<
M"7J"8CF<Z$PC>.9@@#B&;&8SM55]A)XI<YD2NV<#(2O( -'A 2#^B$*4DWC@
M'JZ8DKH$W**9-5F7K+,( F?Z!J)M1M",[WZLL- 4>"8@VFL +8835 'W1( \
M-)@A^[21!* -IP.E>Y/N&-BYOTKTD)I9D^;Z_L%?,M,F4@"T:LL4LZM!B]?$
MC7D3]N+TH7LX^-=$&%#GDP:2 B3JEIJ'=EVJ8/C4AEB]X@36+CR&?1?&PSXW
M[;_D$D5ML>95%J-UIXH8-:.Q M"NG'?'D;\FJ20/VNV""4*W)%C6K%,9C)^I
M =">/O%!ZQK+,??[]FC6NJQR@OC[AJ$)&6C#)]5'C\$UM;MG\)D$MT=^Z-7X
M.\Q;U4FQW>2\Q5GJZC(;#=N5PM0%;=+L-VO,;H:NWL>)5 !:C<;%,&E."W5L
MV5@<#$NG'<;NGR_A) $TTU1::/]+ )HG;;XE/VS%<3I1RU(*I  =8:)?V[Y1
M78;=IG4ZIP'0J(&VDUDZ#QX_0S8RYX\DW/1LTS3-<Y O1\Y?Q,K-NYC Z24J
MEBZ.I1-'HL>$F4H333*]G]W^ YV:G$MD4)1, _L;?SI6%Z_?@J-_IX%&,*_5
M@-$JDDC,_@)YG3"B9P=84Q=5$@R<NG@%DO6S;_L6RB8:2B!/DB@(6U5( OGR
M..#0>B9,XCRU8:]A=. P.S =N2('T(3 8JMZM1CR^[/*,"]:B^W)T&O3H Z6
M,6/H_2?N*5%0Y4H6QY8EL]0528CHRLT[<?+B5;1M5(<:D";X[>0Y_L9,Z)0W
M<<F?AV-;!8*5!3*X _^L5?]< .V?=9_^.YM,W(&LG@@%79J=X5'%7LE6K!MB
MGVY^/<%)M:6^;242;'S(8/1(M9;:<V'F&#;K)DQHI12C>.[H85TXM3%"MU[C
M,6/R8%2I0D\0*^\W:"9RVV?'G#GC,&CH''AY>2$O18>[M*V#*E4YL)'>L6[M
M3[A 9L/Z57/HU0,9'=0NF/XM&6$_*O!*6%P2 IF>@39MV@Q\_?4RAFQ.(%@U
M&46*%$6W;MU3 #0W-S>,&C5& 7 C1HQ"A0KE^7WD&P":7-AOOQW YLU;V-E%
M\_-'%<(IZ]\&H.W<N5VQS$J6+,%0T-&R:4H1+V6O7GV4-[-PX<(8/'@0\N?/
ME_+[ARYD=9OX^_/03'03$W3QV_Z3&#YL)@<+#3M4C(P4+_$[*I+)=309 [5J
ME\>J-0NY6P+\Z,EO3I:@KJD% 37JXNER*LXP=$&J=/0YV"1:\+L1L_"]4H?0
M05Z4S',1G;_P150@PRUH"!M$<9ZNR^H^40RG@&9)HM/&D9*D.9X3V3',N-F@
MTE8.CJ\]I^^X]$_^DQB\4CX5@-:\@2L:T^MWX<IU_$P#(2=I^$-[=\41AL+?
M?OB$8)(!^G7K0&#('L,GS$ T$Y*DS\(IYQ?!0?[4&8J],H/1Y>NW$4Q6CA@-
MDB;<DJPT"WK+[ B<5*]<'JU(<R]1O(@&E.%$)IC>O3JMNE +PX- ?$[T[]$!
M$ZFQ]B%% 6A[R4!363@U#+1W9>'T)"/DTE5O/'$/0YUJN6DX,<,;'0X2LAD3
MDZC8:);9#-4D(3(Z@6&FC\@N"T>U2G9H5C</)V0$AVE(_WF=&?8(K#GGSZ:R
M;HIW6T(_M^US@Y.3.=JU* !GZJAE1?G4?43D,T^$7/P+_@=/(.3V X8ZL1](
M5_A&PZ;V%[!IYHHDAKX\.W@ +\CFBN>VJ?5(TNVFWG6+7+G@2H9OO/M+^!\Z
M@8"SEQE:14".QK'3EX,0S"1$CW?OQ*L+S*+)0]ODRXOB P;"C@X3 P)8Z8L
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MYP3G#+;_=H59.O-@VW<#%; GZW8>N$I=LVB>?S$(@TVR:V[8<1:G+SYDWY7
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M;AT:&=85YR*:=&DB16]>E'16%L[0SU43\2]6$E!+%KP6/9+</9$4Y<9]M*,
MAQ!#.\9T4/O&YRA7:PP8;:4R21(+1<?$D7@;?8'!3]X\)KU[^E:%8)R[CG:W
M_SYY![*Z3;SO34UD.XAC:(.^OA'<'[]DR.P8A 21@2;Q#,D E/;Y"M I;2))
M?A,3B(9"?'P4C848'#NZ#3ERVRIC\Q3IT1-_V A#2S)Z],E BS-!0G@BFE6X
M@RK%_9G!DP84,Q[J:0&N]SWIS&[_NOEJ]N!W 6H38G7@6GX),W@55_97(CW2
MDO;^GU#$P)'R.0 T.4X4PZ/="*)94D-0!/UEO!#060N@B09:FZ;U,9TB_T5=
M-,;%4Z;^7KMA"U9OWDXO6':"3GE1C!3SO$SI+9H-(4S><9>AF\>I9>%+(*8T
M!_S1@WJA0YOF<DA5!-@[06'5;]?^B&-G_F2&+P/690UG&E<%G?+ W,P4(JCZ
MDE3]I]2J<'_^0H5PMJ%@[03JL94OJQD;%8"VAUDXYW]#]D 4%LW\$N]*(B '
M]_:)Q+&3+W#N@C=Z=J-0*YOSMGU/<>T&PR_+VZ);^\)LXP3>V;[/_BE9!V-0
MN& V:B%9*]T=,8"/GGVILG"6*FJ#DD6S*S%RCQ?A:%C7B=Y,Z@G2X9!5Y?^J
MCXCQ]B.(QNR<OQU%R/6[R%Z3 %KO#DH#+?VUB:98($$T-V:F]/Z+(1LT M4]
MY&W0 &C?JR0"$@J9OH23U>O.Q#%/]NQ&3"13P+/#*=BR)?(V;/@:F)).B#9-
M(FV:2!\F=B!;39!\&]I(1G1FQ$='PI<,M.M3IVJR< H#K5U;%.W=1W,X3GP2
MR2:.8]L,8=BI 'T>1X^R+V">:1KR3G7KH,2@03 D4.9'5MK#+5N4!EH\0YO-
M&?)A7ZD*?S.30Q(\8\@BM[-V<895P4(PH)[@YR[23V15'_&YS_V_XWV:._"O
M:Q-\EV@6XD4$Q;0G]T54(L.D. Y0T0'6=KFIP4@ A@XXT9X4+54#:J3J)NJK
M\4G&*1E#!$23,5V/[ZEN7!ATC*U0KVP>G+IX'<[4[7OT[ 4%NIUQ[N0)M.O4
M&3_M_AVZ9CD0&11&87LK G0:W3-)="49_G(:6F+%@N]AQ!!20SK5)+V2V#TZ
MZ6S>3_,$L[[6S+4)7B/[5LT\06/CB9VG.CL9'%61];*<ZG?-#\DXEMRGMX]Y
M HYHG>3)NV7PD?H\,OB9JP3LTP(N&6_QMK7B\)?STUY/ZNU>G[NZ#<HN??NU
MI-Y3NZP M!9: (WGJ3&:M3^G^=0":*X-_O< M$'3%^$2)7',S<TIJ&^MPB]3
M;@YOO@#:$BJ9@^^F9'&O6JXDRA1Q5E(!*=MET8)@)+6Z#E1,+VO:OY,&]42C
M&FF!U=2'$MTW24(025OG[P T 0:;_C_VK@,PJJ()SUTJ$%KHG5"E]RI5NA05
M1061I@B((E:LJ+^B@H(BJ(!@ <&"'00%E-Y$>N^]E_3DDMS=_M_LY<+E2"B!
MZ[/*W;VVN^_;R7NSWTY!YLZW1@YQK"+3[ZP(M..(J;IU]SXD/&A)T7&\4'N(
M3IZ[H%U(+\7$T0:XS'*RKD;(VOG1J\]FJL\;-UQ&H'7MVA4QF-ZA6K5JX0'$
M?\"VPB^%39LV4?/FS>F___Y#C*4&]D,W],UU<X; _OW[7W%=/++-,-/+\62D
MN ^!6SX1LB*#T8K'\$[(3&CQ'7$R@+S5!Y/US,_L9Y/U3>)Z8\%Z%%*\(UG.
M?T_6I,-X/\(MJ]0@$&@';"_&() @>>MB?S"EG5N-=RROQ%V6UXR*F7@K<2<E
M'9F']]25_6%7OMQ1=Y,Q5U8Q$C)J";@?MUPF;A!!?O&;L<H7% +5!!-,,WPI
MGWA\-*WX!^1^>'XH/5PAQCN#[&(5!LJ(8D4$9!J+ D[BC&0SOAM/J10#)XM\
M-&GA*IJ];!WBH$&>TF)H0(?-5#$_8M*@GC2T"8].Z&=9R!$W=[/%KOMP];P4
MB#99#^3-I&0+7#,&4%3Q/K!(0S900NPK(Z^"9:58W6Q';OQZ5GBYW*K)L=T"
MK4W7!\F"<>K>L0V->FH8-4:<B>R*G4#K^QABH,$UHF>W#CI&F9U .X,7^*_S
M_J1/0*(=05!3C@U4" H/QPGD>!0<0^G(L>.PW$J&U59Q&M#[7GKH_KNI E)Z
M.Q8FOU:L7H\LOK_3\C7_(B,O9^Y$0-?\O#(9BGI2=1V<58UC/C1N4)MZ@X3K
MC*"L99#!D8N-0/N-7AJ#&&CI!-JC_1$##:[<V95$) ;8=R &!-X)JHLX9RF(
MB[9M;PR(,A.R;490]<H%J6*%?%JV-VT]!W<?,Y7%_BA8H;'5PH$#<5!JDJ!(
MV9((%$*\,Q:Y4*S0MVZ!3(UV^<NN S>XWY//"#.4N+@-V^CHF$\H3[WJ5/+A
MGA11MWJ6=\#D5L+I4[1Y[#BX8QZ@%)!5#.*U"#2N[,3RY;3C\VD4<_BPQIVS
MXK%K9+GNW2DWD@FPOL)Z4FI,#)U9MY:._/8;WDF*:B%#<U%807)Q)-#"0&I%
M=;F3*MU_OS[&Y[+E6=QA**0K5]"9I<N0"1 6*'B?%:M7ARHA?F:IMFWUN8X$
MF@I'('W$!*SW\LN4JZCWO+NN;V)LNW7Y# P$?%$F%!9H$BVIM/_,(7K^S6<I
M-"_T3/Q=!H<6(&5*H/(EBU$*8M]&@Y /SI4;[VLS+(EX@<*60,I.H!F1I3,(
M[IYXFR-.5GE:#LOGV\H60KTQ%%$@DO)'%J4MVW;!'9TGZ;!L0F9PQ;H(GN><
MA=.<G*(3&7V.YUS)$F7A^HD8;,$@T/ LYX /-IWV%C_8W2"6OB,36I%T$2*N
MK-O692'0KF_H5FW<0F.GS:)C)T_I]WEV5_&(L<)>$XNV+PQ&7-[;*H,DO_4Z
M.B<(^.C+V9H+N1OA35[&0F]6A1=S_UZS 4D&:FC=\EHQT-@MM%O;5O2_&R30
M_MNQF\8AQMO,]]_,"'=B[P]G#>6D!IS-LP06NR>__KS]D-=^NY1 &SMVK+8V
MR^KNERQ90@,&#"!VM\Q)>?WUUZELV;*P*'DD)Y?+-2Y P!43H?C=GU#JN4UX
MP5_Y<#' JB8?2+2T@Y^ 9+MRY5_?(E:&>$TGK *(N%#X?R=MQ I=7?!=YV%2
M7PS5%J"T\VL1S. TZLC>2L>8NS12)94BTZF5Z,N5B@83;WFJ#G !JKY=I2MD
MXH81T?H%!T).Q3^LY$)6%LY?1>^^_3D=.WH"P=8+8TR#H&B:\8UT\>R:"<73
MIKR"+$4,L518E$T8_P*UOZLVYJH@XM)"J/_$]^%VL85ZMHNE" [@"S(+G*TF
MLJS!3,2YJ-C%3S? )!]^8!^[_^:#U5GS6A/0,';@?XZIPL5^B=[PX <KO%QN
M)8&V#=DN'^@W1+M*=F[7FA[MWR?;@/W<-A-HB_]902-'C:8DD&$].K6CX8,'
MP%6Q(A_69N2<_7+^'XMH^;H-= 2!87D[,1%NNK@V%)GY.!9AR6)%J V"P?;H
MTH%J5K\-DYXKGU&QB// _?MEWE^T=>=N!/6/1CT(\LRD+LZ/P")/81!S%<N5
MH;M@?=:L:2.];7??80)MP9^+Z9T//X.%FHE>?>%)D'7W7)5 XWO@X.+GD4#@
M\)%8.G_>!-DP4.'"X90;L7<2$M.H0KG\5 0QS0X@1AH+1T%DZBP R[(S(,Z.
MP86S $BS!&3<3$0F3LZ\618)!"I&Y4><%@2;YP9N8?'D,X)=-RT@T1(.'*$D
M6'7D;]$(1%J-K.\.?V=LT95\\0)MFS213L,ETPS%D[-PMG7(PIG5Q4GGS].9
MM6N0U7,"$E<@0B$FNJ%PDPQ&%LP0K%;G+ER8DD&>I<;&P 4[#<\;$_ZNB8I5
MNXUN#?L5?0  0 !)1$%4>[@?%:I;A\YOWI*1A9,M () PH:D$ZG\M#'@7J#0
MZ9AN;#''KB'Y2I;2\=;*M&M'P>D+BN<V;Z;]WWU+9]>L(<*DO5C5JE3WA1<H
M3YDR677=(_M\9V+L$7@"LE%?DPG6/-.P8,M9+WG"^>_N3?3"V%?(@H15)8N7
MH3R&6"J2AY,#&*A0B>H(_'V2+B7%4SY8BW#R(_L[("@8I!OTBF+Y0N@<,OM&
M123"LLQ$#2LCJVN8E?9>--.6DXCM2_"RP-^\*2$&]9>"R_XQN(9"IX710OSY
M2_3A6Q]0XRH-H12$X/ECI! 0;0:X;QJ@S]ATWUO]9'>]F/J:3-PL(JSR>6*4
MA$"[OI'CQ#/SEZVD[^8OIEW[#^KLE[D0%Y<7R/A]K!.XX/W/;KOQ6(!CE\46
MC>K1V.>?0+SB="^IZVOJNLZZ /V1K<EB8CF+<E6:^M9+VLK,^>(YT$_Y>=.U
MS>W\",G6 LV>A3.G!-I&$&A#1[]'HQ[K1_<AI(ES6;=U![(^+Z=BB"<[<N#U
M)+APKL&]VQXCT#C[7XD2)>@8'O)L268O;%' ;I[\ F$SYOSY\V=RT^35>BY,
MH)6!PC=HT"!MZAR&51N[.R>OU/,*CGV;S^=]_#+AH-!Q<7$Z\R$+C'/]?*Z]
M\#5\+D]0.2LB_Q$\BG3OAPX=HG^1E<M>N*]\'O>=ZR]8$+&RT'Z@%5=,A"S)
M<+/Y=Q3>&EG@"?OXB-L&$<4BMDS"_FO #=-L3'XQB!1:?J!VPS2 ++'1'==X
M)8$5"2E]%R4>^#$;DDW!S:4<A97N<(T^!-YA5\A$CE"$YL&33(757[;8XK]E
M IFV>-%:FC9E%JQN3F)R#/=<$ ]&6#P:C% JL1[,DUBM<%IR(SAJ-*W8\#5%
M%LJ%;%=6B@]-HQU;AU <9#0-;ABA)DR*T0:<M,"Y03'%;Y<472UDE@.LH>@X
M&%"(\^<I3\WJ?H@7-5L288(=C"QZZ!%;GUU#PEW2S:PJ98672YLV;?3WS7XP
MH74<!-?4:3,TN56M>C4D"F@)BZK+[Q3G-OAYO@O).[Z9\X..-56S5DWJV+XM
M%<LB;?81N%9N0I;/W7OW$5NF<6;*D- @Q%(K1<V:-*0ZM:HCH'X^YR8R;7-[
ML2!IMD-Y^&_+-CJ-U<DD6*^%X/W&\09KU:B&NAJ R+4%[G>\F#-S;L8UO\]?
MJ"W?[N[1E9HW:XP,?39BU/'<K'YO1];,Z!@3XDLHN)"&Z]AGJ8C9=O!@'-6H
M'JGCI;$50KZ\;&5FH(.'8ZG&;9%T\&@,Q<6GZ;^'/!$A5!$!E$LA$+8KBL>?
M$9 A,\A)\X5H"H[,1\&(39)=X;%4K*/LW4,'?OF%3J^%>RY(K#;7(-"LT!'L
M)-K!GWZB!+@R6&"!R$28D2U!X&)EA3)M1=W\GM)QR3"1KMK[(2K=N@U(MMPV
M"[377M,NG/JYQ-?R<PQ%NQ#AF__.#=C'F3,+X6^A7)=NL&!K2.%P%^']7,YO
MV4+[OIU#9T"@&4"@%47(BWJC1@F!IM&1#V]%@-\=;6[1>\-=]ZCCD*5;B:=!
M[UB\ 0MWD\91).*7-6Y<AD[MVT#E0)Z'YBE%:[<=QM]]/AV:!G-L/=D.Q]]G
M"I/T2'H5:T;B@> XZE*!J%ZE$K1QUV&J6+$H[3B61'^M.T1YX!::-Z( 19_#
ML]N A -)L%>#Q7U(FI'>'O4V+(^K4FXC)NGHC_VY@0U P?]LSP9WX7*KVO$%
MF4C ,WTEXIO:,ITBQ ;>OXV*%@+Y&4XG$6\J#N^&:@@5D8SSMF%QYD2BB8KF
M"J'&2 P1BD4V?B\?QOR2R=@JL#9,!)NZ+?HB'8]/1JS;8&H.':(@W +MKI_1
M</??>"D6HVK3#]D3HB06:ZHCA(3VK(#>N!JQIUK"^I%CM-F(6MO9%V&I>#HI
MD6J!P' L0J YHI'][YT'#M'4;W]!UMMXG6FS/#)*AH +T!CC?<WZ ^NL')_W
MPJ48FO7;0G@SG*!YTR=2&<3)O=6%";O%\((8/_T;)!-)HONP2-N[6T<=H)]U
MA?/HPR*$(HF-3Z1>7=I1*2P*<PRTGL-'03>\0.5*EZ)Y4\?K;FF]^> 1NO^)
M%S2WTNV.EG#A')IMESF3Z, 7WT)&T7-P,Z].7X\=36R!]LB+_]-D7K>V+:A+
MJV:4-WUA[_")T_0=%JW9O;5MTP8(=5(ZV[J]Y8#'"+2SB//!0?Z92.,@YCPX
M)T^>U*Z=3%;5JU>/MF[=BM7S\SJ6&EN;<1DW;AQ] F65"2LFJY@ 8X%\#8KE
MP($#]3E]^O2A9@C0^R0"]=I++V2@8K+MN^^^HQ4K5FC7T;6L_()4V[ESYQ7N
MGG_^^2?=>^^]V@65^[=RY4K=W^G3I^N^V=U##R#>2,N6+75R!(Z]MGKU:DVD
M[=BQ ZOUV2OB]G[YT[=+)D*0B^CU3V-5/C%+J)391 4;OT4I^\;C!0*"+/VE
MD>7)O!/NGB$5!I(U%H1;5J2<\X58G0LNWH52SF] ]C8$9$8K5Q2KB7)7>A!9
M&3._=*XX+P!WN$0F;AA'*!*LQ$(\^(L0TRS-DJ"?'U8KK$"03C,),<R6+5U-
M_Z[="W+A)$C\TS#.X#@D"G_W)1$CJB2UZ=H0Y$(4!:5A/U@'Z,.(G7>>5FT9
M@HEO/*5",8$G,(4B!IJ61)O^<L.]O=8%K"AQK"(.IL)QK%CD0PT%J77]][&S
M."SD^$4-RY80SNJ5AK-YC=L[%&16>+GXVD1(=]I'/XZ?2J#5ZT^#=#-2J^;(
M^@4KLA,GXNC0B02XDAHILD 8%IC@GAAOINJ(>5:L:"YZ_O6UM&-G#-W3K3SU
MZ54)EG+96^?>+"S>\8S 7>!=PW^RM@G%U>^*W3DO;-].QQ8BD^>>/=0,>DFN
M0H5A"!V:[85,O*7$Q8*X6DL7H1_$'#I(R5!24^/C0.2"N(<^$X(8>[D*%Z%\
M%:*H2(V:5*11(\H-_<.":R]!3]G\SAB0\W#/TCV]W!3'!&42+AB!_O.4*$X%
MRD=1@2J5*1)) T+S9\YF=7'W;CH"\N_"YHV:0(O$N36>> (NG+=>@;_<PQO[
MY0L3XQN[(SG[9A'P19G@>0WK"?R= @+$C,GTH5/':!3<.2V&TU0M"H160BP5
M*HZ_UW*50(J=H;.GSU)A_IM'+,K8V 3$,@V'S@'+5V3^5DFGJ5^+$E0%F1+7
M@7"K43F24D.+T:P_5E*%!K5HU[X#B/$*LMZ$[.-(R5DRL@2->VDL%<I?"(M^
M1EB?Y+FNY]O-CI6[KO<%F5B#Q9)Q:Q >!L]HGCXHL*-W5ZM" VZK0=-V[J"%
M"*9>"238T8OG$:>.WP-XNH/TXGBK7[;OA- )1GK]OTVTX_1IJ@#7MD.8.[-U
MH]9GX7X;C/?!)^W;4;'PW+3^_%EZ=]4:+6\<;\M>>(&E3&0AFM2Z%6W%G/HU
MA!1HB) 3HQLVSGB7,-G;%XERTF =_U./[OPBM%^..;:B>^^82,?WG]/6[!#G
M; LO0H^;WH<Z=*V5[3FN.N!)>>"_\6&(@;8=?X./].JA@^!SK+#L"@?49_)J
MS*=?TM=P::Q8IJ1+_C;30-AN@O?#ZDW;:?.NO50$V2VY7QSO+%]$'JI0MA0U
M1!S?XD4*:3?21!@./8V8NY=@[5JR6%%D['U&WP+?'Y-<S[[[H5[ ;=6X/CW1
MMU=VMP</B&AZ;>)4D'315*UB%#)V#J4=D/5?86'6NDD]6K=E!\**< (!DXW+
M05]J5*Y +1O6U?'CKD</R[9Q-QWP&('VZ:>?THP9,S0Y9K]7)J XMME]]]UG
MWT5,6 T?/EQG]&3"S%[XO/+EH=R#+',N/7KTH!8M6M +<$NPEV[=NFG+MNK5
MJ]/GGW]NWTVCL/+Z&^*-[($2;"]L%<?90ID$JP$%E L+3T.LY#[UU%/4KU\_
M^ZG$??[XXX^)DR;8R^3)D^E5!/N]=.F2PTJ/_:C_?KMJ(I1VX5^*W3X)+Z"L
MX_X80O-0P;HODVGGZ/2'_N4'_Q5H(QY%2(4!(- .X-QKD JP< LJ6!ON5FEP
M\]R2C?49P3J@!(65N?.*IF2'YY,(9#\&>JJ<Y6%6#ECAL)?+J[7V/9>_S7"W
MHN SM'H+S*133E 8KQBRX@&MV8KX)[HP:\?_C!QHENO&WO1#&35AORY9[4<2
M %U T#%AQ@'<#; X,\.:+@43[Z(1-:E)C5>AF!7#"O8U9-I6D\<^6<'A(@2:
MAL$M'Q;(H2G%0B=/Q=/QDPF03:)"!7)I$=R\_0+%Q*5@I3$OW#KSP3+;YK:Y
M8LU9[69Z9X>RU**9+1Z;JSKKJO>&J_IKKY>MQ2[MVD6GEZ^@BHA%E@LK_(:K
M*,P9U^%O-N[@ 8I!%N1$Z!HI;+W.<9$PP0J#-6-N6.;GKWH;%;SMM@R%VL(6
M;%A@/+5D,8CS8*V/V.OC;UY$Y"R:8;!FR0?=)3^"_P<CSEI6)0$3L5B0?PG'
MC^O^AL/ZH42K5A2"9 />4CPY$?(6#*0?F1'P-9G@5SEG9&0"C=_*'..',S);
MH%<:L;CUSOAGJ5CA-*I1OC#] @OC8)!F6TXD:Z(E/#27?OZ&(($66R9;8N&V
MB:R99M,E*A,63U$E(A'[K!2%F1)IX^[3=!Z&J['6)"I4L@A=1,9Q\X54ZG1'
M)WKFL:>Q")A&X4@: /6#@A%^P)^*;\B$H@2X[#V_=CVLQU)H>MNV.IXHOXBG
MX_TQ?]]>ZH=D,5U*E]'RPLN=,P\<I(68DPZH5Y?NCHJB-T&@;3UU@IYOW)CJ
MX7D-/DNKE"N1H&8*DMJTJUB9GJQ3BYZ#5?%AA)MXI\7M5!J)B@R\F(K_QFW;
M2IMA33^Q?7N*@F7SZQO^P_91&EBW+MU3J:)62D>N6DF'SUVD9YHWI=9X!UTN
MJ %R>_84K.!@)6U752\?M^FT[+[(A:W:BA2/H A8M;O;LM&3\L 8->TUB")
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M_8Q]V'0H5BNLP])"D T+5)R* Y&5!VU8\'P)=3C+_I/KY\)U<AM</S?.^Z'
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M9!HT8 @(MEA:NG@G#1C4G18O6@W"^QSUZ7LW"+@?J4FSIE2V3"D,N94VK#]
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MA+-X<W(CM((D25H_ +&GB]9).+:6%9X]2-"4FD;W/M"/?OA^-N4*96=!A*2
M^YX5A![RC.,2S^L5GI8)&W#RZ2T(B#QXRT@$1C^$0,MBG*.CHZESY\ZT:]<N
MJE>O'A4H4(!.GCQ)NW?OUME#.4E _OSYL[@RL'=YVT1(F9/)DGP:A-I1LB0>
M)7/\<7R?HMR5^E!:]#X*#LM'AK!"9$1\,V-X40H*S8^$G!&!/8BW^.Y=(Q-,
M=D*!@\*G$("?DSO,_7XQ?3G]-WJH7SN:-N4GJGI;69!B8ZGU[0]0C[O:4JG2
MY>GCCSZC-?_^2-_/64JC7GB3GA\UA&H@D.OPQ\;0R.<>I,%#>Y$92ZX;-VVF
MN;.7T9IUZVGYJMG4I.&]]/)K0^G8\6VT8LE%^NC38=2ZQ6 Z<F(!"+3/Z="A
MX_3<\T-HZ+#A-&GB9&W5UJG3';1CUW9:O6(K?3;Y)]JQ?RZ48*PJASB[&#/!
MQ86U5]P7*Z6<>( +KR#KW_9S;+MMY_)Q^[;3=?;=U_K.N/Y:)]ZZXZS@<!$"
M3<,@'T# -<\(@=:7$9")D"^/GFOZ[FF98%+)B-6OS9OWT+,OC*5WWAE%*4D@
MH4!NE2A93"<TNG@IADQ8:'_FV=$TX<-W$/0]#;%0@ZE$B3)XYSU(TV>\2Z7*
M%*$56%@K7"POW7WWG?3G7YMH]JS?H7_<A[KB8'V62E6J5J(R94IB^<N"UWP0
M??OM$GKNV7=I_8;95+AX7DHSA5.'=O=2NS:W4^^^=U$($AS]^O,B6K 0EOC+
M?L':[T4, I(?960"AY4:P8I-)S=B'1<+R^F+:QP&P\Z%(90\]O,_PD)@/-6L
MVYWV[EH&0BT)F<%S0QVQ6=0%Z7J91/-L\;1,>/;NI75G!$0>G!&1;5<B( 3:
M5=#E[)\;-VXDD\E$^1"DL6'#AEA9*G25*P+[D$R$ GO\L[I[U\B$C4#3F8.0
M,3,H*!@QR_;1;[\LIK!<9JI5JSIU[=X1^\UT]DP,31C_*24GI<'%\@D$.RU*
MID0KO3?V0Q!>?2E/W@B08)_0B)&/4)%B^9 B/ P)17ZBOQ9LI.'#'Z7JM<O2
M]LV':,974RE76 2]^LK+4) 30=+]"%+M,1WG[.+%,_3 @_?2M[/GT9(_-U/9
MJ%STRNBGZ<TWQE!,3 (-'C2<:M<O"<4820PR"#2V*N-_G*V3"3+.%,J%5W59
M?4UGMYRY,SY%'^+K6(%-/X_W9W4N[\^N:!</OLC>'O>'B^M6EEG!X2($FH9!
M/H" :YX1 JTO(R 3(5\>/=?TW?,RD8I7;#)MWG*<7GWC75KPZVS;C>*U:36D
M:K=&*Q;VDI$ K=4=G6GMFN448F0KKV#:O.D@/?G4:%JT^#L*R96*P SA"/ >
MAV.A" NQB?[Z:SE],.XE79\5"VT*5EZI*0CY$)9;ZRZ]'WZ!0D,BZ?T/'Z/2
MI0K25U__B9BO*^F[V1-@"0>K,K01C.R.Y\]%4][\(104$D*(%4]K5FV@TZ<N
M4JVZE:ANW=O@/FK"HF-NBKYTB1;_O02_@ZA3^PY4(#),!YP/#\N%ONZFW;N.
M4:D2Q>C18:_2KIV_(G$2NX7"V@ZJ@I6@<Q$O!+I.3]! 7,>'YV7B.CHII[@-
M 9$'MT$M#0$!(=!$#&X9 C(1NF50^DU%KI$)&X'&(*593/C$6JHE%(D"$NG2
MQ1C*7R WK$8+0@$%.83_0SEQ*BM^B!-BA0L&G'PU9:2OPW&CD;,:(9H)8I98
M$)\D*-A",1<MM!I9=SMW:8G]X8A5PFX4091J20$)!A<&8P29DA%O!-X01KA$
M_/CC/*I>LP*R!-= K+,DO>K\Q^_+J77;IG '96M'$U6M6AE)!K91I\[LFL%Q
M1ECQ13R4(%[QY9@FH;J/!.(/J2OHTH5X*E@D%SR+T7GTC1.3&(T6Q%M!.G3<
M16A('A"$E^B/^0MHP,"^NAX+\.#LHIQ]R18?CIT[C,CJE 8EF-O@>^64Y38"
MSV" 2RG:UIE!=9_0MH[YYQKEF!4<+D*@:1CD PBXYADAT/HR C(1\N71<TW?
M/2T3=KUA\Y;]L#"; &NRL908&TN%(_-2R3*1>*^R39>!$D&@M6QY%ZU9^Q>%
M,>D$.%+QSN[0_A'H)A'4Y^$>U*GU[90K;PB%YPJ#!=J_]/UW"^ &VHU,";%4
MNTX5*EN>,XA;]8);SYX/TQ-//4Y3IRR@CR:. +%5A![H,Y(>?:0OM6U=&[H!
MNV4B"[@A%+]A(89W?9+)0#U[]J4B18I2QXYWT,2)4Q&2I@\]]60_VKSM(-US
M=U\:]O@ ],Q*'X[_BOY9,8>J5JY(GT^;0].G?T^][^]+.W<>HK^7KT3LUU\1
M H/=5]$,]!"V91,73M?(N-1Z<PAX^AEQ<[V7JWT. 4RFI @"MP2!UU]__9;4
M(Y7X#P*ND0DS^"=@A']FLPD_+&KE\HVJUFT=U(AA[ZBWWGH;^WB_4BEIY_6W
MV9*$LY+U;]N'1?V]>)5ZZW\?83--(;-FQK%4<XPZ<?R,FCIEAC);[-=P@Z@O
M)5F9K1<RSN5KN0P?^I;Z^Y\EZ?O-*BTM27WR\6QU_OQ%]>GD66K"!S/4V=,7
MU.=3YNASQK[WL5JR>$7Z^4JEIB6K5).MC31SG$I)MJAJ5=JIQ*38C'/L/^(3
MHNT_U8&]1]5=W1[6V^:,6["HI.1$O<]B35%0J/7OM#23@AM*QK6,75I:2L9V
M:HH5./"V)6/?K?ZQ=.E2Q?^D" )V!%SSC+#7+M^^B( \(WQQU%S;9T_+A.T]
MFJ8V;=JCZM;KK1X9_*;J]_!3:O)'7^'&TZ".I.#]:5%Q\8FJ3KTV*M&$]ZC%
M@GUXGZ==4I=B8]7<'Y>H(<->5S6K=%*S9\W5@"U8L%%U[C)$O?[F9^JE46/5
M_'F+\,[&NQC7+OYSC7IBV&A]7K<NP]29,Q?U[[M[#%=;M^U7::FV=_4GDZ>K
MELUZJOJUVZN#!XZJ/Q:N4P.'/*7/3<)[/R8A1=6NTT-=C(E7';OV5K__L4R9
MS!:5D&I2/\_[1_5_Y%EU*29.5:G61)TX=4:EH/U+N(\*E3NKQ!0S[B$!^A9T
M"31W68/0U7OTP],RX=&;E\:O0$#DX0I(9(<+$6!K!"F"P"U!0"9"MP1&OZK$
M-3*13J !*1OAH]0;KWV@!@T8J;%CY7/OWKWJV:?_I[<G??2E6KMF@UJ_=J.Z
MK_M+ZJX>]ZJMF_>HIO7ZJML;/:C^6;I(S?]MD>K98XBZY^[>ZOBQ(VK_GI-J
MQ/#1()C2U(LOO*=>?>E]U;73H^K?=7M JB6JP8-&J7MZ/*+>&?.!;F/$XZ^K
MYT9.4'=V&*X^&#<-^ZQJQ./O@8@["2)MIOKH_6_4D4,GU?]>GZCKJ%>[DVK?
M]B'UR]SE:L##3ZMD4[+:NFF_>N+Q%Z \IRA8SZDJY;HI4W**>N6EL>K-USY5
MG=H_K*9^.DNW-^OKG]&?@>K9IR:H[G<.TOLF3_Q:];ASN!KUK*U/+XUZ2\W]
MX1>U>^<!-?B1Y[3F.^Z]SW#^PVKT*S@'?-V77\["=A_4_Y%-.=8LG(W(TY7>
MX@]6<$3)N<6@^GAUKGE&^#@H =Y]>48$N !D<?N>EPDSWOTFM7'C#M7MSOZ9
M>FC%XIQ5I6+IR:)BXQ-4PZ;M5&P2+\PEJ50SDUYQ^,TDFZW\O6R]:M2P%XZE
MJ%\7+E1/C9R8?L1V1C*(L1.G+ZF*5=NIW^:O5$O^6:4ZM!^A9L_Y RU@P>[)
MT6K"^)_Q&RVG)JISERZH$R?.J49-.JK#1T^H-\9\K*;,^!ID%XY;4O4R7^-F
M=ZEM>W:JJM5;JT-'SZGXE!@<BU7[#QY7M[?NI8Z<.*^JU&BLDE+-*A&D6W0B
MVH]JJ5),6!#$8AOK)58+$WOI7?6"+\_+A!> (%W(0$#D(0,*^>$&!(1 <P/(
M@=*$3(0"9:2O_SY=+1-F<ZI"=EQU$A9CC1O<J1K5[:E6K]@),FJ/:M&TE^[H
M\*%OJ$6+%JL!_4:J9T>^HRZ=3U 6K+Y^^,%7ZND1[ZB4U"2U'Y9<>W8?5./'
M?:[8.FS;YJ-8S>VN2:;JE;JHOY>L4K_\\HOJ>=<P7>>F?W>IW;MWJFJ5NJIC
MQPZKIT:\B)5BU'T!J[9EFZM3)\^INC4[JAW;]ZA//_Y!,;FU;>MNU;YU?WU]
MGUZCU/3/YH,@2U:UJW52!_8=5L\]]9Z:\LE,'$_0UFA5R]T-(LVD.K09K,:\
M_;[:N^N4BBK=1B7$):OR)=N"Y#NA/OA@@NK2\2%U"LIOA=(=U.&#IU6_AYY4
ML[Z>JXX=.:N:-+Q;=>LX1*U9M4GMWG$4[0]4Y\[&JM;-^ZAM6PZINK5;J=]^
M6J[B8DUH$Q.$RV9LNI^W^H,5'%%R;C6JOEV?JY\1OHU.8/9>GA&!.>Y7NVO/
MRP0322EJ\\:MJFOG!VU=!=^E%_&8'(-YEAG;L7'QJEK-9K#Z2L7['5;>J5:U
M:L4Z]<6,;_ ^!ZD&W6/%ZJVJ;IU^NHZ%BY:JQQ[]2*68S2HAT:02DDPJ&=<=
M/7E&O37N8_7F>Y/5&_^;I-I"#QCQU%B5A,6V?0>.J-*ENL+J_3\0:&G*!-(K
M)C9)U:W?2>W<O5]MV79$M6S=$Q;LR2H9EN6;-Q^!!=J=R@2+\P$#7U/CQ\\!
MN68&@9>J7GEUJAK]QB<J&M9I%2LW5X</'U=)N&;;CGVJ0KG&RI3$5NQ,U:5_
M"X%V-3&58QY$P///" _>O#3M=@2$0',[Y/[;H$R$_'=L<WIGKI8)MC9C LU>
MOILS7U6I>+O:]-\.U;X="#"4?KU?4[_]NDB=.!*GGA@Z6A4KU%PAV*[Z9.*W
MZNDGQNASNG4> ')MK'KQN0EJS%L30: =4?5JV:Z_O5$?93*EJ-5K5JE[N@U7
MV[?M497*MU=3IDQ3U2L\J/;MVZ^&#GY9+?A]HZZK5;.^FHQK6*^]VK%C#UP\
M?E"3)DW5U[5MV5>?\^!]SZF?OEL*I=2D/ILT5WWX_DS5KF5_*-BLJ"9 Z5:J
M6L5NFD!KUVJ06KKL;TV2U:K:#83=*56K\GW*"D.\K5MVP7+N";5GUU%8K-VE
M'G_L#?7DXR^K'^<NT)Z8[5H_K&YO_* R8T5[WJ\K5/.&#^/X&^J%IS]2V[<>
M5AO_VZFZ=7Y$=6Q_GU;LV>*.,755805'E!Q7H>N;];KZ&>&;J 1VK^49$=CC
MG]7=>UHFV*4R!>35NK4;U!UM;;H!]],""R\VW]9NEWAUGK\4"\NQ.BHF/DGQ
M>I0)X1A.'C^OVK6]5S6LWT$UJ-]>5:C46*U>>4#?YB(LSE6,Z@9WR88JJG(K
M5:E:2]7[H2':T@QQ77&.+1Q%Q\Y]U:G3YT%[P4+=DJ;FS5NOJE;MI)HU[Z::
MW=Y%155HH4:,& ."S:(N1B>K]\=/5S5JM5*=87%>N4I+M6;=/A!\3+295.LV
MO57;=EU5LQ8=5>?.P]2%2RDJ#<38S-GS5,5*3527KOU4C[L?594J-%#)26;H
M/[! @X6=%=>S&Z>W%$_+A+?@(/VP(2#R()+@3@0DB8#/1:WSW@Y+,&CO'1M/
M]<S5,@&E%4'OC33O]_FTXI^=M&_?,03Q-]'77T^@IDT[TJ!'^].W,Q?0V/'/
MD"G)0!<N7:0W1T^@#5M^IA5+-R)#YQ?TQ5?OTN!'7Z ^?>ZG!0O^HJ;-:M ]
M]_2BW@\,HMT'EE*]FMUHY9H?:<NV3?3ZJ]/HA5$#Z)FGQM&(9^ZG5Y[_DE9M
M^)(FC/N"MFW;36W;U:;??UY/F[;/HQK5F]!O\V8BH^=_R#003>W;=2"X4M+Z
MC0MHZ.#7Z/CQH_36N\,IJFP-:M[D7FK1H@E]_M7_$'0XA2SF,*I0M@D=/+*"
M6MU^/[WY]C"J6;,^U:O3GDZ=W4PMFCU C1O70(#? Y26&DI_+IFN^]EOP+UT
M*>8L/3Y\$'TX81)%1.2E@@4C:<6*Y?3--U^@KIXT\-$'D)GK$CW_PF,T>_8<
M9.NRT(\_S:%5:Y90<'"PQM-5\B))!%R%K._6Z^IGA.\B$[@]EV#0@3OVV=VY
MIV4"5EBZ:YQ-.S$QD2*1J$CI3-:<! @9L3E1$0+M@U^B&&2YS%\H$NEYN.CH
M^T@0I.CPX<.4E)Q,Y<N7H[QY\^)Z$Z6F6B@N)I4,1B06X@0^N#XDR$ %\N7C
M+&]LY$!6;$<C05*!R'Q(^,,)B PXQIDV373L^#%D^$ZE(D6+4?'B1= /9 M%
M4J0@0S =/W$:B94N4H4*%2@B;V[T+P%Y!G(A08&!#AP\J-NJ7+D*]!.TC_X;
MD0T<"W04'Q]/5:I6H=CH6(HL5!#'..D0IT.P90GG<[VA>%HFO $#Z<-E!$0>
M+F,AOUR/@!!HKL<X8%J0B5# #/5UWZBK98()-"ZG3Y^F9?^LHCQY\E#'3NTI
M=^X@6KEJ/9T[<YZJW5:/"A<+H^/'SM.___Y'MS=O0=5KE:*TE"!DL%Q.5:L5
MH?SY2M+2?U93Z]:-*3$YB4J6*$4;_MU '3JUIF5+UU&KUHWHPH7S=/C@>1!S
M=>BO/U<@LQ:R9!8H1;7JE*$CARX@HU8HK5^_AAK4;TK5:I:G?Y:LHD:-ZU+T
MA01*LR939&1AVK9E%TBVIE"PDVC>O 74I%D=JE*E*C6HU8,^FO0F-;^]+A)N
MIB&35@@M7;):G[MVS2;TL1SE"L]'6/W&OL9T\4(<+?IK&=6I4X=,IE2T4Y7.
MGDV@)4N642B2<=UU=S?ZXX_YR,#5'GJOD9;\O9RZ=NU )XZ?I>7(K)4/RGF/
MNSK2DL4KZ=2IL]2U6P<J5JPPVH6*;'2==LP*#A?)PJEAD \@X.IGA(#L>PC(
M1,CWQLS5/1:9<#7"OE>_R(3OC9DK>RSRX$ITI6YG!(1 <T9$MG.,@$R$<@R=
MWU[H#IG@%5K^9]2KHU@!QC(PKY!:K08*QL*P!:20(2A5$TE&K/":S1:LI2;C
M[' L&F/%-\A$RA*"E5U.T8[SL)ILQ!$L\N(:"ZZWH#ZSMLRR6E!A^KJR$2O!
MI'"](1FKP;RZBSJ-H01/#[UB:[6$DC$8]>';$(35:ZX0_YO-9@HRAJ > \7%
MQ]+ _D-!KI6@J=,^T*O0!DX5C]/Y'O 3]\$KW%PG5IWYEX'[@^IX%9JW->L%
M#*Q8=38&X=NV$L[KQ7R=%3M"@H/)E&RF$*2C#T(?<37JL1%U02#,%'&=O%+.
M]X/#+BJLX' 1 DW#(!] P!W/" ':MQ"0B9!OC9<[>BLRX0Z4?:L-D0G?&B]7
M]U;DP=4(2_V." B!YHB&_+XI!&0B=%/P^>7%[I())M 0@Y>,(*J,<#=@$BHM
M#>X&3**!-&("#(%*0&X%4U PNT"D@/3*A6V05898N#ODT>21E4P4;,A-9K!N
M0<$&;8V%N!_X!@]F ?$5% +W2J-V$PT-#0;79 01Q219+I!=*2"^0D!866 %
M9L!YW%8R.#BX3, MTP#W"-)$')-XJ3C/ %>*( H)P3=(/W;G,!C9?2,")!CO
ML_7!:F7WBC#(AQG7@^HRA^ >L:G=*LRX!GW ?7'=A#JL(-(,<-\PXI^%^PZB
MS(C[0Q8P]#$>YQ; -6DX%__0-^WN$8S?S)S!+40(-+_\4_3:FW+7,\)K 9".
M78& 3(2N@"3@=XA,!+P(7 & R,05D 3T#I&'@!Y^M]^\$&ANA]Q_&Y2)D/^.
M;4[OS/TR ?.KC*)9IHRMS#_8:HWMMU!T'!/]*_,I3EM,TK$5V)4EW=8+Q!G'
M0D'-. ]G:8LS>SMZ+_;;SL5!G("3[%^H&VQ?>OT<9\2Q.%Z#2[A>[#+@-%N?
M^%Q[O^SGVH_ICMB.ZT.,C[U^Q]]\D(N]'MO6K?YD!8>+6*!I&.0#"+C_&2&P
M>SL",A'R]A%R?_]$)MR/N;>W*#+A[2/DWOZ)/+@7[T!O30BT0)> 6WC_,A&Z
MA6#Z254B$WXRD+?H-EC!X2($FH9!/H" /"-$#)P1D(F0,R*R+3(A,N",@,B$
M,R*!O2WR$-CC[^Z[%P+-W8C[<7LR$?+CP<WAK8E,Y! X/[V,%1PN0J!I&.0#
M",@S0L3 &0&9"#DC(MLB$R(#S@B(3#@C$MC;(@^!/?[NOGLAT-R-N!^W)Q,A
M/Q[<'-Z:R$0.@?/3RUC!X2($FH9!/H" /"-$#)P1D(F0,R*R+3(A,N",@,B$
M,R*!O2WR$-CC[^Z[%P+-W8C[<7LR$?+CP<WAK8E,Y! X/[V,%1PN0J!I&.0#
M",@S0L3 &0&9"#DC(MLB$R(#S@B(3#@C$MC;(@^!/?[NOGLAT-R-N!^W)Q,A
M/Q[<'-Z:R$0.@?/3RUC!X2($FH9!/H" /"-$#)P1D(F0,R*R+3(A,N",@,B$
M,R*!O2WR$-CC[^Z[%P+-W8C[<7LR$?+CP<WAK8E,Y! X/[V,%1PN0J!I&.0#
M",@S0L3 &0&9"#DC(MLB$R(#S@B(3#@C$MC;(@^!/?[NOGLAT-R-N!^W)Q,A
M/Q[<'-Z:R$0.@?/3RUC!X2($FH9!/H" /"-$#)P1D(F0,R*R+3(A,N",@,B$
M,R*!O2WR$-CC[^Z[%P+-W8C[<7LR$?+CP<WAK8E,Y! X/[V,%1PN0J!I&.0#
M",@S0L3 &0&9"#DC(MLB$R(#S@B(3#@C$MC;(@^!/?[NOGLAT-R-N!^W)Q,A
M/Q[<'-Z:R$0.@?/3RUC!X2($FH9!/H" /"-$#)P1D(F0,R*R+3(A,N",@,B$
M,R*!O2WR$-CC[^Z[%P+-W8C[<:FW-[X  $  241!5'LR$?+CP<WAK8E,Y! X
M/[V,%1PN0J!I&.0#",@S0L3 &0&9"#DC(MLB$R(#S@B(3#@C$MC;(@^!/?[N
MOGLAT-R-N!^W)Q,A/Q[<'-Z:R$0.@?/3RUC!X2($FH9!/H" /"-$#)P1D(F0
M,R*R+3(A,N",@,B$,R*!O2WR$-CC[^Z[%P+-W8C[<7LR$?+CP<WAK8E,Y! X
M/[V,%1PN0J!I&.0#",@S0L3 &0&9"#DC(MLB$R(#S@B(3#@C$MC;(@^!/?[N
MOGLAT-R-N+0G" @"@H @( @( H* (" (" *"@" @" @"@H @X%,("('F4\,E
MG14$! %!0! 0! 0!04 0$ 0$ 4% $! $! %!0!!P-P)"H+D;<6E/$! $! %!
M0! 0! 0!04 0$ 0$ 4% $! $! %!P*<0$ +-IX9+.BL(" *"@" @" @"@H @
M( @( H* (" (" *"@"#@;@2$0',WXM*>(" (" *"@" @" @"@H @( @( H*
M(" (" *"@$\A( 2:3PV7=%80$ 0$ 4% $! $! %!0! 0! 0!04 0$ 0$ 4'
MW0@(@>9NQ*4]04 0$ 0$ 4% $! $! %!0! 0! 0!04 0$ 0$ 9]"0 @TGQHN
MZ:P@( @( H* (" (" *"@" @" @"@H @( @( H* NQ$0 LW=B$M[@H @( @(
M H* (" (" *"@" @" @"@H @( @( CZ%P$T1:-LV[?>IFY7."@*"@" @" @"
M@H @( @( H* (" (" *"@" @"/@O K7K5W;)S0F!YA)8I5)!0! 0! 0!04 0
M$ 0$ 4% $! $! %!0! 0! 0!=R,@!)J[$9?V! %!0! 0! 0!04 0$ 0$ 4%
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M3PQ38'=2)D*!/?Y9W;W(1%:H!.X^5G"X"($6N#+@?.?RC'!&1+9E(B0RX(R
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M=P:1T8KH/ [,"U<N36XP6Y_3G[!$O7A\[%SQT]L6S?A?A*HUXGN]6CP@D@A
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M:Q+$2@7A.:_6E(%VMJ+#.@4;3Y=-4O-9LB0"6&>,N)#!>B[N=>-:.<.B#QF
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MN'*6X&+<N&/OD/U'N:X(9?\(9;X'(A.9Y[GI-8I,F#Y"F6V?R$-F^9TMM0F
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M$Y(PM."D"_'ZM.Q;SMQYM^)CS98,HCT7OQUQFI;T5+IE(FF%4L!H#F"! Q(
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M%C@@ = <-L@_YH#,$2(&7@Z((N3EB!R+3(@,>#D@,N'E2+B/11["/?Z9[KT
M:)GF> [7)XI0#@]N";LF,E%"QN7H95C@@ 1 <]@@_Y@#,D>(&'@Y((J0ER-R
M+#(A,N#E@,B$ER/A/A9Y"/?X9[KW J!EFN,Y7)\H0CD\N"7LFLA$"1F7HY=A
M@0,2 ,UA@_QC#L@<(6+@Y8 H0EZ.R+'(A,B EP,B$UZ.A/M8Y"'<XY_IW@N
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MHI]^^HE8D7;*N^<.WF0+Q3HS")E(]_..,>_9LZ>C@V*.AXYX]=57$X.I1>0
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MX9UE1]D!",_6!C'7Y.)!T(I0*CPMC7D" !I;9CH@"=KRUEMOT5__^E=GDU8
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M.<1^[ZA1H_QBMW1>9"!$66A,?!L@FDL,_AG$4![J )",>H3<F0 4"74*H0
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M[]T<TU-9_&R&/Y2Y5<K3$:0; ]"R=$2L+I +9(RZH[TA<]*'N[Q#;O"*!@0
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M1)&T0AT-Y<1E'C (0PCW>W@@KLY9,P&A_)@5Q(!CV0"-'  -8 ;RZP1C#L\
M(>2 ?,DOYMG(\UGU@MR1ACL#X0[2)"]^Z=R1<\ 3P&0Z=MZEG+?>>JO[J%4\
MOJ+#1988::#Z#!H 9/IM"2<#';Z70,2R'!7O@2P/5+\.6YE=@;%^.J[^"0U$
MI'/@73F.S>#PG$MXY,H2=;G.),'**Z]L3_, M+PV@LZD[="&2 LY.O744R6K
MGO]BX!0U<@ 6\+IB, 9(#)^RZIEE.WRKN_1:@ -TGV_L-%-G, T> D:2!\N
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MVVH+L>RA&0"-CC0$H,721@'2B876RW,=XS5$+(.3LG$?-UE<["$&[\13<4D
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MLP'%X0N#!YXE)A@DH)E[3)GYGB>??-(^0TP#@M/SG56BN@Z$B!'%#G^)FN=
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MO]!R2[Y#/&3<]&+'N';./__\L4=Z>L\U4D,%(6Z#V]CE&;S'!*R2:WC980Q
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MB^ 36P CB\8BP61[_>FX7E,>68K8Z_*$\L\;"('NAV+<<9U&CQ+#)1ZO/XP
M@IU#OJ&3!Z#AC8;1B^LL 0QIP!@N>+^QK +/1D %XDPT"Z"QE!A%BK&$K##+
MR9+?%U]\T>[B4B3.7HAW=;V6)Q. 7-3O::>=9F=4J#-BS6 (%HUQ6 1 HT.D
MXR0&'H&D:=]Y,N'+71: EB43>"1B#",C&-E\D\2!].O;[4!#'9]T4/Y[G/OQ
M(?T.V 70LLJ*_':#,'"*&#G=*$O*HQH<R-,1U2AE*D4W.5!$1Q0%T/ .P@8
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M VN 63M++ FV\39+J8;D9Y!3N\:8@)=EDW%3M.N5C?M@;M(//OB@W94Q]\'
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M4$@:E!-  62Z*MXP:2 4DH[!OI8G$WD &J[6 %V QK1%=_FW"Z !<!.O3 @
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M>>IZP $'N)=??MFIYU??OGU+WU<:PJF$F))>.^ZXHVTW;MPXM\,..[@//OC
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MO;7-6:8AGAK&J636T*%#W<HKK^R>>^XYM]IJJ[E%%EG$AEV6]T#3?&N:X^S
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M&I\R$X?G1B@3S91J(8F)5+D7^)/I!XX6$FC&P$L0X!I!&,0"W C%(JP3$\1
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M6*38Z\1#L=L_]=K7*ENGGF+JJ1429*53J#=:2'[9>MP#+<R39CW(POQD#?9
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M(8%F#+P$ :X1A$$LP(U0+,(Z,4$,Q +$1"Q2['7BH=CMGW;M2:"E+<[Y$$
M 0000  !!!!   $$$$   00R)4 "+5/-16$10  !!!!   $$$$   0000  !
M!-(6((&6MCCG0P !!!!   $$$$   0000  !!!#(E  )M$PU%X5%  $$$$
M 0000  !!!!   $$$$A;@ 1:VN*<#P$$$$   0000  !!!!   $$$$ @4P(D
MT#+57!06 0000  !!!!   $$$$   0000"!M 1)H:8MS/@000  !!!!   $$
M$$   0000 "!3 F00,M4<U%8!!!   $$$$   0000  !!!!  (&T!4B@I2W.
M^1!   $$$$   0000  !!!!   $$,B5  BU3S45A$4   0000  !!!!   $$
M$$   032%B"!EK8XYT,  0000  !!!!   $$$$   000R)0 ";1,-1>%10 !
M!!!   $$$$   0000  !!!!(6X $6MKBG \!!!!   $$$$   0000  !!!!
M(%,")- RU5P4%@$$$$   0000  !!!!   $$$$ @;0$2:&F+<SX$$$   000
M0  !!!!   $$$$  @4P)D$#+5'-16 000  !!!!   $$$$   0000 "!M 5(
MH*4MSOD00  !!!!   $$$$   0000  !!#(E0 (M4\U%81%   $$$$   000
M0  !!!!   $$TA8@@9:V..=#  $$$$   0000  !!!!   $$$,B4  FT3#47
MA44  0000  !!!!   $$$$   0002%N !%K:XIP/ 0000  !!!!   $$$$
M 0000"!3 B30,M5<%!8!!!!   $$$$   0000  !!!! (&T!$FAIBW,^!!!
M  $$$$   0000  !!!!  (%,"9! RU1S45@$$$   0000  !!!!   $$$$
M@;0%2*"E+<[Y$$   0000  !!!!   $$$$   00R)4 "+5/-16$10  !!!!
M  $$$$   0000  !!-(6((&6MCCG0P !!!!   $$$$   0000  !!!#(E  )
MM$PU%X5%  $$$$   0000  !!!!   $$$$A;@ 1:VN*<#P$$$$   0000  !
M!!!   $$$$ @4P(DT#+57!06 0000  !!!!   $$$$   0000"!M 1)H:8MS
M/@000  !!!!   $$$$   0000 "!3 F00,M4<U%8!!!   $$$$   0000  !
M!!!  (&T!4B@I2W.^1!   $$$$   0000  !!!!   $$,B50LP3:1]]]8A"K
MM.V2*1 *BP """"   ((((   @@@@  """" 0+E S1)H-[Q_FYWG@!Z[E9^/
M]P@@@  """"   ((((   @@@@  ""&1*H"8)-/4^N_&#.PQB_U5W<?1"RU1,
M4%@$$$   0000  !!!!   $$$$  @3*!FB30U/OLX^\_M=-T6[*SHQ=:F3AO
M$4   0000  !!!!   $$$$   00R)=#B";3RWF>)!+W0$@G^(H   @@@@  "
M"""   ((((   @AD3:#%$VCEO<\2#'JA)1+\10 !!!!   $$$$   0000  !
M!!#(FD"+)M J]3Y+0.B%EDCP%P$$$$   0000  !!!!   $$$$ @2P(MFD"K
MU/LLP: 76B+!7P000  !!!!   $$$$   0000 "!+ FT6 *MH=YG"0B]T!()
M_B*   ((((   @@@@  """"   ((9$6@Q1)H#?4^2S#HA99(\!<!!!!   $$
M$$   0000  !!!! ("L"+9) :TSOLP2$7FB)!'\10  !!!!   $$$$   000
M0  !!+(@T"()M,;T/DLPBMX+[>:;;W;++KNLVVZ[[1*2S/Y]^NFGW:NOONH.
M.N@@M\@BBV2V'A0< 0000  !!!!   $$$$   000:$B@V0FTIO0^2PI2Y%YH
M7;MV=:NOOKI[Z*&'$HY,_!TT:)#KWKV[&S5J5*F\)YUTDKOHHHO<C!DS7+MV
M[4J?\P8!!!!   $$$$   0000  !!!#(DT"S$VA-Z7V6P!6Y%]KTZ=-=Z]:M
M,Y=PVF"##=RJJZ[J_O[WOR?-Z'[XX0?WW7??N1566*'T&6\00  !!!!   $$
M$$   0000 "!O DT.X'6TB"77'*)N^VVV]R##S[HEEIJJ=+ACS_^>#=UZE1W
MZZVWNL<??]R===99[O777[>A@WW[]G5GGGFFVV2334K;-_1FRI0I;N>==W:[
M[+*+&S]^O'ONN>=<ITZ=W!__^$>WUUY[V:[[[+./Z]6KE^O7KY_3L,MITZ:Y
ML6/'NCESYCB5Y1__^(?[_OOOW<"! ]VEEU[J^O3IXQI3]OWWW]^MLLHJ[NRS
MS[;SO/?>>^Z88XYQ&@ZYZ**+NJVVVLJ.T[Y]>_M^V+!A;N.--W8GGGABJ4J'
M'GJHZ]"A@_O?__U?^^S""R]T(T>.=),G3[9DEK;_RU_^XI)CE'8,;[3=#3?<
MX*Z]]EIWP047N#?>>,.=<,()[JVWWG)_^]O?K)X++;206WOMM=TYYYSC!@\>
M[/[?__M_[N*++[;RK;;::J5S?OCAA^[__N__W)-//FF?R4S)M+ESY[H[[[S3
M+;SPPC:\4SW5%EML,=M&^QQ[[+'FI_.HK%]]]96[\<8;K6>>;<0+ @@@@  "
M"""   ((((   @@@L  )+' )M.>??]ZIMY,2,X<<<HA1??GEEV[EE5=VIY]^
MNCOLL,-<CQX]+,%S^.&'NUFS9KDQ8\98\DP)L,8LDR9-<KU[][;DFY(^*ZVT
MDB64/O_\<_?::Z]9TDP)I+???MNVV6BCC2P9I#(I2:?YOE0.);RNN.(*]^]_
M_]NV54*OH;(KR3=@P !+%-URRRU6=B6DE$@Z\L@CG7JG77?==6Z--=9PSS[[
MK'VN89/;;[^]N_SRRTM5^\UO?N-67'%%J[>28<.'#[?]53;5[9IKKK'$H))Z
M\?(___,_[HPSSG"++[ZX)?VZ=>OF=M]]=TLB_O+++VZMM=:R).&($2.<DGM*
MRDV<.-')6DF[???=UP[Y^]__WMU^^^V6N/SYYY_M,YG);_WUUW=*_+W__OM6
MG[OOOMOMN...UEM-=5.;'7#  78N)=KNO_]^IW9?;[WUXN*RC@ """"   ((
M((   @@@@  ""/SZ GX!7/KW[^]#SZY2R4+O)Q]Z,_E//_W4A]YG/JCYT%NJ
M]+W>A*&$==8;6GGGG7?L&"&)5=HL)'OLL] ;RSX+B22_[KKK^L\^^ZRTS957
M7NE#LLN'7ENESQYXX ';;\*$"?990V77!CIFZ.5FVZI>JLL33SQAZWK1.?19
MZ(%GGX7>:OZHHXXJ?:\W(:'G=]II)_M,WX6$G@])J=(V/_WTDP])K=)Z^9L_
M_>E//@PA]:$'7?G'I?>S9\_VH8>>#XFY.F4+23$?$FVE[?0F]("S<R<?RBP\
M',&'1%SRD0^)2A\>,F#K(0EHQY19LJCNJF](H"4?\1<!!!!   $$$$   000
M0  !!!!8H 3< E6:_Q3FJJNNLJ1*Z-%EGZRYYIH^]&BR]S_^^*/OV+&C)8&V
MV68;'X9">B6_FK(D";1QX\;5V2T,XRPEII0,VF^__>I\'WK$60(M#!GUR;\P
MS-/*&H9$VK8-E5T;E"?0#CSP0+_DDDO6278E95-R3<O\$FAA"*J5*?0.L_)>
M??75/@PMM7TKO2B!%GJ?S?-5&,;J0P\V2X@IH97\T_&U-#:!%IMML<467O^T
MR$_U51LF"PFT1(*_"""   ((((   @@@@  """"PH HLD DT]:9JV[:M#W-E
M^6>>><:2.4DB1Y!A2*<_]=13K2=6FS9MK'=:F#>MT<9)DJH\@:9>4V'^+K_;
M;KO9<2HET/;>>V^__/++^S#L<)Y_86XOVV]^92]/H.EX2GR5]]@*\[Q9?<\[
M[SP[GA)H87BGO4]>RGN@Z;,PW-.'N=6LMY<27V%XIP_SBB6;U_E;*8$FSS <
MU8?AI5XF'WWTD7_II9?JN%>;0!LZ=&@I@:8RAJ=UUJDO";0ZS<,* @@@@  "
M"""   ((((   @@L@ (M,@?:J _O=I-_^#3D;N:S^(5L@VY+KN3V[/[[!C?6
M'&.:VRP,";1)ZC4?E^8*TP3U>HIELFA^M TWW-!I+C$]$$#SD7W]]==NV667
M=:&W4[)9G;_)'&@A663SB^G+5U]]U:VSSCKV< +-I:;YO+2NR>V3)22?;/)_
ME45SAY4OH6VM?/JLOK+KN_(YT/0@ 9TK)*M<&/JIK^V!!9IG3/.+Z2$'FA>L
M9\^>=9Y^.6C0()NW33ZQAQZ^$))6-O=8Z.%FQRQ_T1QH^J<G:":+'HZ@.<T>
M>^PQM^FFF]K'>JB YE"3Z=9;;VV?A^27/4@AV2\D^>:9 RTV"[T$;4ZU,,35
MR4\/)"BO;W)NYD!+5/F+  ((((   @@@@  """"   (+FD"+)-!N>/]V]_'W
M4QI=MVY+KNP.Z+%K@]N_^.*+I4GEE:@YY913;/L[[KC#_?6O?[4G88:AG39Y
MOQ)-FDA?$_J/&C7*A9Y=]M1(/2VSTI(DT)1@TGY*%NFIE9]\\HD+O=,L.54I
M@::G@"JIU*5+%Z<RA=YA]A3+,&S3$D-#A@RQT]57=GU9GD#[^../[8$".I<>
M,*"'""BI%N8PLW)HHG\];51EN_[ZZRTAJ(<&Z"FE80XT2S"&(9,VN7_H.>>6
M6VXY=]---]G3,_644#U!,UXJ)=#TA-&N7;O:Q/]A3C5S4/WT4(0D@:8G<NI)
MG#JWGJBINNM!""IW^4,$&DJ@A3GL+-'9JE4KM\<>>]A33-6>>K(I";2XI5A'
M  $$$$   0000  !!!!  ($%1J E>L6]->,]_]Q7KS3ZW]MA^\8LH?>5UQ#-
M\'3,TN8A.>63><<"H@VI##VV_,R9,VV;D$"SH8?)'&*E'<O>)$,XP],W;5L=
M)R2$_*.//EK:*B2U;%ADZ8/_O-&04@W#U#[)/Y4S).7J;%JI[-I PR0U=#-9
M-&12PT*38VG2?0V?3);0V\V'1%CI^VVWW=:''FE^YYUWMDU"<LV&12;[:VZV
MBRZZ*-E]GK\A@59Q#K20("L=1W.DZ8$!.F;R,(-WWWW7;[SQQC;?FCY7N<\_
M_WQKG^0DE<PT3]V66VZ9;&)#<D./-FO#\'11K_/J>"&)6=J&-P@@@  """"
M  ((((   @@@@,"")- B/=#>GOF^^W;.=R$/TKAEZ87;NM[M>C1NXWJV^N:;
M;UR8Y\N&-VIH9U.6I >:AG"&I) -9PS)M*8<PGW[[;=./=(Z=^[LPGQM3=HW
MWCC,@>;"@Q!<F(?,>H+%WVM]\N3)U@,MS)DVS]?:7V51SZZFUJ/\8!K^JG)T
M[]Z]WN&O(9GIPA-1K==;^;[5OK_PP@M=F,_.A:>H6L^V:H_#?@@@@  """"
M  ((((   @@@@$"M!%HD@5:+(9RUJK".6YY "[V@:GDJCAT)A"=RNAX]>M@0
M4 UA'3ERI VCU3!8%@000  !!!!   $$$$   0000&!!%&B1!%HM'B)02RPE
M;G;<<4>;,TT]T%C2$SCZZ*-=>/*F"T\K=2NOO+(+0U+=B2>>Z,)0W?0*P9D0
M0  !!!!   $$$$   0000 "!)@BT2 *M">=C4P000  !!!!   $$$$   000
M0  !!#(E0 (M4\U%81%   $$$$   0000  !!!!   $$TA8@@9:V..=#  $$
M$$   0000  !!!!   $$$,B4  FT3#47A44  0000  !!!!   $$$$   000
M2%N !%K:XIP/ 0000  !!!!   $$$$   0000"!3 B30,M5<%!8!!!!   $$
M$$   0000  !!!! (&T!$FAIBW,^!!!   $$$$   0000  !!!!  (%,"9!
MRU1S45@$$$   0000  !!!!   $$$$  @;0%2*"E+<[Y$$   0000  !!!!
M  $$$$   00R)4 "+5/-16$10  !!!!   $$$$   0000  !!-(6((&6MCCG
M0P !!!!   $$$$   0000  !!!#(E  )M$PU%X5%  $$$$   0000  !!!!
M  $$$$A;@ 1:VN*<#P$$$$   0000  !!!!   $$$$ @4P(DT#+57!06 000
M0  !!!!   $$$$   0000"!M 1)H:8MS/@000  !!!!   $$$$   0000 "!
M3 F00,M4<U%8!!!   $$$$   0000  !!!!  (&T!4B@I2W.^1!   $$$$
M 0000  !!!!   $$,B5  BU3S45A$4   0000  !!!!   $$$$   032%B"!
MEK8XYT,  0000  !!!!   $$$$   000R)0 ";1,-1>%10 !!!!   $$$$
M 0000  !!!!(6X $6MKBG \!!!!   $$$$   0000  !!!! (%,")- RU5P4
M%@$$$$   0000  !!!!   $$$$ @;0$2:&F+<SX$$$   0000  !!!!   $$
M$$  @4P)D$#+5'-16 000  !!!!   $$$$   0000 "!M 5(H*4MSOD00  !
M!!!   $$$$   0000  !!#(E0 (M4\U%81%   $$$$   0000  !!!!   $$
MTA8@@9:V..=#  $$$$   0000  !!!!   $$$,B4  FT3#47A44  0000  !
M!!!   $$$$   0002%N !%K:XIP/ 0000  !!!!   $$$$   0000"!3 B30
M,M5<%!8!!!!   $$$$   0000  !!!! (&T!$FAIBW,^!!!   $$$$   000
M0  !!!!  (%,"9! RU1S45@$$$   0000  !!!!   $$$$  @;0%2*"E+<[Y
M$$   0000  !!!!   $$$$   00R)4 "+5/-16$10  !!!!   $$$$   000
M0  !!-(6((&6MCCG0P !!!!   $$$$   0000  !!!#(E  )M$PU%X5%  $$
M$$   0000  !!!!   $$$$A;@ 1:VN*<#P$$$$   0000  !!!!   $$$$ @
M4P(DT#+57!06 0000  !!!!   $$$$   0000"!M 1)H:8MS/@000  !!!!
M  $$$$   0000 "!3 F00,M4<U%8!!!   $$$$   0000  !!!!  (&T!4B@
MI2W.^1!   $$$$   0000  !!!!   $$,B5  BU3S45A$4   0000  !!!!
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MZ+]#+8JQCS_^V-ZK+/H7>L&9N3Y46;1??>>O5#=9*T98$$   0000  !!!!
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M32W+JIZ&FCM-<P6R((   @@@@  """"   ((((! ;05(H-76EZ,C@  """"
M  ((((   @@@@  ""&1<@ 1:QAN0XB.   ((((   @@@@  """"   ((U%:
M!%IM?3DZ @@@@  """"   ((((   @@@@$#&!4B@9;P!*3X""""   ((((
M @@@@  """" 0&T%2*#5UI>C(X   @@@@  """"   ((((   @AD7( $6L8;
MD.(C@  """"   ((((   @@@@  ""-16@ 1:;7TY.@((((   @@@@  """"
M  ((((! Q@5(H&6\ 2D^ @@@@  """"   ((((   @@@@$!M!?X_DS7-=!"S
..4-      245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>chart-22b986bd4a964014b65a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 chart-22b986bd4a964014b65a.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEXD\36]I-I<4CD*HN98)F>W4L0/,,9C499V1030!^L=%>6_MF?MA_!?]@_\
M9D\2_M;?'N_OX_"'A6&U?4I='L3=7#FYNH;6%8XP1N+33Q+DD !LD@ FORYN
M/^#V+_@GNGB<65K^R[\8Y-'\S#:B]KI2W&W^\(/MI4_3S!0!^S%%>/\ [#G[
M=W[-'_!13X"V?[1G[*_CO^V_#]Q<O:7D4]NT%WIMXBJTEK<PMS%*H=#CE65U
M96965C^=W[0G_!X]_P $Z?@W\0M3^'/@KX*_%/QA<:-J,UE?:E;Z;965HTD3
MLC>49[GS6^93]Z-* /UQHK\__P#@F9_P<A?\$_O^"G'Q3M_@!X$B\4^"/'U[
M;R2Z5X;\:V,$:ZKY:&21;6XMY98Y'5%9]C^6Y56*JP4D?H!0 4444 %%%% !
M17SU_P %3/V][3_@F7^Q+XJ_;*OOA=)XRB\,76G0MX>BU@6#7/VN^@M,^>8I
M=FWSM_W#G;CC.1D?\$C_ /@I#9?\%5?V/K3]K/3_ (02^!X[KQ!?:7_84VN#
M464VS*OF><(8<[MW39QCJ: /IRBBB@ HHHH **** "BBB@ HHHH ***_,S]O
M+_@ZK_X)R?L3?&/4_@#H>D>+OBAXGT.]:SUX^";:V_L^PN4;;);-=3S)YLJG
M@B)9%# J7#*5 !^F=%?#7_!+K_@X*_8,_P""JGBZ?X2_":[U_P )>/8+-[J/
MP;XUM(89[^&,9DDM)899(K@(.63<LH4,WE[59A]RT %%> ?\%(?^"DW[.'_!
M++X 6W[1O[3O]OR:)?\ B*'0]-L_#.EK=W=U?2V]Q<)$JO)&B@QVLQW.ZJ-H
M&<D _G%I_P#P>R_L!3^(UL]1_96^+UOI33;3?I%I<DZI_>,/VL#/L)/Q- '[
M.45Y3^QA^VO^SE^W_P# +3/VD_V7_'B:[X8U&62!WD@:"XL;J/'FVMQ$^&BE
M3<I*G@JRLI9&5C\ _&O_ (.V?V$/AY\3/$O@_P"$GP$^+/Q1\/>"[GR?%7CS
MP9H=NVE6P$A3S8WEG4O$65@LD@B1R,HS*0Q /U4HKRG]BO\ ;1^ '[?_ .SO
MHG[3W[-7BN35?#.N"1%%U;F&ZLKB-MLMK<1$DQRHW!&2""K*S(RL?+?V/_\
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MQ_'9R75MX1\:6L,4FI11KNE>SF@EDCGV+\S(2DFT,P0JC, #[NHHKRW]L?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC]C7]AOX@^$[7QAXNL-&76]6O]/FFO-1O)8X#J%_*DF^:0DJ6(&%50B*J*J
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MP^&_A7Q+HW_!-WP]K_\ PLC7-2BFGTK3[-KZ6>-4FD>ZN[U99IPQFP SMMY
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MK#\4_A)\,K7]AC]K3PM\%([6WNKCXR>+?%.H6UI;VZ^3:^2%E-M.Z$2?:?\
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M7Q+;S:I!/:PE(U:PO;*.]MFA>-U=E=8V+"4A@NP%_P!+?^"+G[2__!%GQO\
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M-]JVF0:9X=\R:5I8((I;":*62-K>X26W;_684B3!*E#FY_P;(_L^_&[]M/\
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M.\<:/XC\.>';?3=(\$Z9=V$7AZS$$2QQ017OFF<0J% !-J6P.YYK] ?V8O\
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M^.[IXCBUK6H9[%1J%MJNHS^3$L",G[^% N7;"Y!R3FOU-_X-I?\ E"!\!O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\8Z8=%\7>'+#5;-G#FTU*S2>(L.AVN",CUQ7/_\ #/?P#_Z(?X/_ /":M?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_:WT;1K?5O$GQ&N=6M8=$UA;R)[*33K*V^9U VMO@D&/3![T ?C5_P &LO\
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M26D76G?#F+5_[)\"IK$,[B6]TN[L,PVNG1)86V/M(9I0QD<1A2#PP^>?"_\
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MGP)X2\0:I>VWBFYLWM=7EDTZY$K.(X!,'8L6R97)/7.:_$O_ ()E?&2Y^/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX*F?M=V2>)_B,-/NY]&CU#2(=/AU)KG6#8:7(\%JD2B#$L,AVA6>)2P;Y@U
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+X*_M'ZK;^$=3\;>$YO#FF3Z](+98-9MKV*3[!*TA B>0),H#$9DC2,99U%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %?F7_P5&_X-=?V*O^"C7Q5U']H?PEXVUCX4>/\ 6Y#+X@U/0-/B
MO-.U:<];F>R=D_?G W/%+'O.6<,[%J_32B@#\0?A'_P92_!NS\66>I_M0?\
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M%H)X^DD;8&5/0@$$, 1^W'_!/[_@HK\+?VY?!7EVGDZ+XUTVW#:_X7DFR0.
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MC;X;\=:$ER;:?4?#FJ)<+;S@ F*55.Z*3!!V.%;# XP0:] H **** "BBB@
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M<D-UH _<;]N_]KKPW^P[^R1\1?VH]:T%]</@/PM+JW]@6MRD<MVV[RX4)/\
MJT:4JI?!P Q 8C:?YV_^"9'_  5=_8 TO]I'XE_\%//^"J7Q.\2>*/C]XL-Y
M9^"]+TSPC-=:=X5LGA,2M Q;"OY9\B-5SY,*MEF>9]OZI?\ !'/_ ()0_MO_
M  QU+XS?%W_@L=\3/"_Q>UKXT:5I&G:CX7UF3^W((;2RDNI!!<+<0BV\O=<
MK;Q(T2;<@Y.!]2^)?^"2G_!,.]\.:A9Z/_P39^ ,=W+92I:R+\'M$0K(4(4A
MA:\8..>U '\[/_!J9^WU^SU^PY^VMXCTKX\ZEJMO-\4-*TSPKX4&F:6UR)-1
MGU*$1K*01Y:9898]*_JSK\0_^#>W_@W9^/'[$?[1WBSXI?\ !1+]G[X8>(K
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M7]%?,WPN_P""N'[%GCWQ / OCKQMJ7PR\4@@3^%_BII$FB74+'@!GF_<9)R
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MJ[6[U^3<;Y.L)BEC:2]VIOY2_P#MEKZIGMY?7YX>S>Z_(]%HHHKX0]$****
M"BBB@ HH) &2< =37\]W_!:__@Z"_:J\.?M ZCX _P""5WC6WTSX>_#W4ET3
MQ9\2%\-6>J6VN:U,)66"&2ZAEC2%%M;@1LN&F,4[@M&J$@']"-%?*/\ P2?_
M &G_ (Z_M/?\$EOAQ^U+\7-;3Q#X^\0>#+W4+^\CTN*!;RZCN+E(P(+9409$
M:+M11GZG-?EQX?;_ (/3?VL]!_X6WI6NVOPTTVZB,^E^&KZQ\/Z/.5(SM%O/
M#)=1GMMNF5A[=: /WUKP[]F;_@G1^R=^R-\;?B9^T9\%/A_<6GC3XNZPVI^.
M==U'6+B\ENYFGFG98_.=A;QF2=V,<853A!C"(!^4?_!!3_@N_P#\%%?B[_P4
M4O/^"77_  4>M+/Q#X@$NM:<NMC2+6RU'1=6TJ.:2XMKG[$JV\\6VVGCW!-W
MF!#O<-7[FT %%?%G_!;SXU_\%._A%\!/!>C?\$H_AP_B'XB^+O'D>DWDBZ!%
M?#3; V5U,URS7!%M;*)(HE,UQ^[&_;U85^1W[9?[5W_!VI_P2Q\)Z-^T]^U5
M\=+*[\+:CJ\5E=B+3/#NI64-S(K.EM<Q6ULK0AQ&X#Q%5R-HD!900#^D2BOA
MS]B;_@LGH?[2G_!&O5_^"I'CCX?QZ?J'@SPGK=WXP\,Z;.PADU'3(I&>*W=]
MS*D^V)DW%BGGA69MA8_EUX&_;W_X.,OVI_V#/B+_ ,%F/A]^VQX0\*>"? VN
M7(M_A=9^#K%EGLK=H3<F+SK24M&@GP/.F:5O*D^92$W ']%%%?$G[!/_  6%
M\$_'S_@CG;_\%0_VB;.T\.KX<\/:E+X]M-.R(OMUA*\+K;*[$YN&6(Q1%B0U
MPD>YB,GC/^#>;]J'_@HC^WI\"O&/[;O[:OCR >$_&?BBXB^$?@NS\/V=K'IN
MFPS2B6?SXH5FN$\P_9HS*['%H[G<9 U 'Z'4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% &)\2/B5\//@[X%U3XG_ !8\<:3X:\.:
M):FYU?7=<OX[6TLX1@%Y)9"%09(&2>20.IK^4K]H_P#X* ?M$_\ !P+_ ,%
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MM_V@?'.KZGXFN?"OBF?Q2E_J/FJ^IF\@-PY",8L^:9.4^7GY>,5_3A7\R?\
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M&_BOX<N_!(OXY[K5?"]B\.J75K<K;FTM/LU]+(TLC$LAD2--B,SO'BC]D?\
MX.W/^"7'[2WC35/!OQ"E\5?"06.FW-_9ZOX_M;865[%"C2/$LEK-,5N"BDK$
M5_>-A$9W94;\S_\ @W.^%'PN^+G_  <$?%K2OBK\.="\36FF:=XPU#3K77])
MAO(K:[36;9$G1)58+(J22*' R [8/-97[>O[/OP.T7_@[AT+X):;\)/#D7@S
M5OB[X$.H^$ET:'^S;A;JRTN2Y1[;;Y;)+))([J5VL9&R#DT ?I3X#_X/$?\
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MTS1%D6":" 1Y?S9BS*[@92)6" O(&C_*S_@HS^UC_P $G(_^"0_PR_X)]?\
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M.M:1/=7*+C;$T]Q:22B,$;O+#!-WS8R<T ?KS^R;_P $??"'[/O_  1JOO\
M@EAK/C!)KOQ3X$U?3O%WBBSA+*=6U.*7SKF)6VEDADD58PV"R0)N )-?E/X
M_8D_X.)/V5?V ?B-_P $8/!'[!7AWQ5X5\<ZY=?9/BC8^+[(0PV5RT N1&9;
MF,!)!#E3,D<B"63*,=NW]6_^"+WPR_X*X_#+X:>-;'_@K=\5K'Q7XANM=MY/
M"%Q8WEG,(+(0D2J3:PQ $R8/S GWK["\67^OZ5X6U/5/"N@+JNJ6VGS2Z;I;
M72P"\N%0F.$RMQ'O8!=YX7.3TH _G2_:'_9?^*^A>!?V:/\ @U;^#'CZ"_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ K\QO^"I?_  :X?L9_\%&OBOJ/[1'@GQ_JWPF\?ZW*9?$.HZ)ID5]INK3G
MK<SV3O&1.V!N>.6,.<LZL[%Z_3FB@#\3O@1_P9=_!CPS\0M,\8?M._M\^-/B
M%8Z3/'):Z5HWA>/1BPC8,L33375ZPCR.0@0X/#*>:^\/^"O7_!)33/\ @K'X
M%\&>"=2_:1\2?#@>#]6NKY+OPY9K,]Z9HDCV.#(F NS(Z]:^P:* /P^TS_@R
M@^$6BZBVL:-_P47\>VEVX8/=6OA6WCD;<<G++< G)Z^M=]_P<*^=_P $Z?\
M@WZ\*?L%^$_'>I>)]6\3:CH?@*PU6XAQ?:E;P,;V:4HI8Y<6B1, 3G[0!WK]
M@ZR/%7P^\!>.I;&X\;>"-(UB33+@7&FOJNFQ7!M)>#YD1D4^6W ^9<'@4 ?,
M/_!%G_@GG9?\$X?^"</@O]G'4+&.W\5W]BVM?$"YB +2:W>(K3J2.&\A1%;*
MW=;93U)K\Z)?^#(+X#32---^W[XR=W8L[MX,M26)ZDGS^:_<RB@#\8_V=?\
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M?$NMSK-J.M707:LD[HJJ%1<JD:*J("Q W.[-]%44 ?GA_P $X_\ @WQ^&O\
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MK,'FQO:+<A;Z2\4&= Q"PQ<HNX;>#_0)7YD_\'<O_*&3Q-_V/&@?^E5 %O\
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M1]/LP/3= +C'_D>OF>OT[)Z?LLLI+RO]^OZGT^#CRX:*\OS"BBBO2.D****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6DUGX6!^36M0(]],0?\ M:E>R\)AL1ZWJ)'J=+C'_M>CGB5_;.6/_EXON?\
MD9E.CD:)BRA2"I5E=0RLI&"I!X8$$@@\$$@UH/9^%@V(]:U CU;3$'_M:F/:
M>'@Q$>JWI'8FP0'_ -&T<\1_VOEDE9U%^/\ D>9>/?A:+>*;7_"4!,,8,ESI
MX)9H5')=,\L@[CEE'/(#%>%KZ#$>GPS"6VU&Y!1@4<6X5@1T/#\&J=A^R;X@
M^-LE_K'PU:QLIK(J;J.]9HH;@MN(V;%;;)QROW,'.5Q\WM8/,XI<E9_/_/\
MS/D,UPV7I^UPLU;K'_+_ "/"**[;QY^SC\<?AI%)=>,?AIJ<%M#%YDU[;Q"Y
MMXE]7EA+(GT)!KB:]J$X5%>+NO(\0****H HHHH **** "BBB@ HHHH ****
M "BBB@ K^EKX5ZP_B'X8>&]?E;+7V@V=PQSU+P(W]:_FEK^D/]FQG?\ 9T\
MO(<L?!6E%CZG[)%7YUXA17L<._.7Y(]3*W[TOD=K1117Y@>P%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHTLYI2TJ1:]-0/@NBOHOQ[_P3;^+&A"2Y\ ^*-+\0PH%\N"7-E<R,>N%<M$
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>XM*^-DGC._\(:9\/;6QFTM-1U**6413.)7E,</D0O,\L9:-P!Y>/,2O!_\
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M_@[^UQ\!+J]^'GQ$T[Q+X+\;Z%=V5OXB\+:I%<P75M*LEO*\$Z;XV(.]<_,
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M_P"">0\9PZOXBNYVCOM?\)O%/K>H):O//>7MSD R-' 0. JA41%50H !H_\
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MW-@;VV_UEN)HFC\Q/]I=V1[BODS_ (+9?\%</^'.W[._A?X]_P##/W_"Q?\
MA)?&B:!_9/\ PE?]D?9MUI<W/G^;]EN=_P#Q[[=FT??SNXP?3OV%_P!NW1?V
MP_\ @GYX4_;Y\2> V\&Z=X@\-7FM7^AIJ9U(Z=!;2SHX$RPQ&8[8"W$:GG&#
MC) /YC/^#A#_ ()#^#/^"3/Q:^'WA[PI\>_$WC^;QYHE]J&H:CXHMXTFA>WF
MBC50R$EP0_4GL*_JU_9:_P"38_AS_P!B'I'_ *115_,3_P '0O\ P4^_8Z_X
M*;?%WX3>+?V/_B!?:_8^%/#>I6FM27V@75@899KB%XP!<1H7RJ-RN0,5^\W_
M  2-_P""K_[$O[??PZTWX*_LQ_$;4-9\0_#_ ,":3_PE%I=^';NS6VQ"D!VO
M/&JR?O$8?*3TSTH _+'_ ()9>-O@!\&_^#E?]K^^_P""@'BKPCH&H7%]XK'A
MG4?B1>6UM:[9-;@EB$,EV0BL^GE&C ()@W@?+N%9?_!NO^T;\*_V5/VD/V]O
MVS-/NQ9_ ;P?8W&HP-IZ".VG3^UKQ])MH!PIEDA\R*)/691QNK]E?VRO^".?
M_!-+_@H#XT@^)/[6G[*.C>)_$4%ND']O6^IWVEWLT2#")-/83P/.JCA1(6VC
M@8%?E?\ \%8_@A\'_B=^U!\'O^#:3_@F-\.=,\!^%=0U^#Q;\<)O#<;,;:(1
MB5#=RR,TD\L5HK7)\]VWN]@@8%0  <[_ ,$MOVNO@5^QSI'Q$_X.(/\ @JYK
M]]'XY_:(\37^E_"+PQI.GF\U&;2K>1/M3643LH6%2D%JLDCQK'%:*N\_:%#?
MHM_P3\_X.-/^">7_  41^.D7[-'P_A\=^!_'%]"\FB:!\2O#\%C)JNR,RLD#
MV]S<1EQ&"X1V1F4$J&P:_.G_ (.5?A/X%_9'_;Z_88\0ZMX1&F_ 7P##I.CI
M:K:M-9V=KINKVTMW"R@'<QLO)R#EI!&WWL&J'_!0OX\_!+]OO_@YY_9*\2_L
M#?$+2?'/]A2>%V\4^(?",OGVYCL]9N[^[1I4&)/+T_<7.2 K;"<J5 !_0S11
M10 445XY^U7^W7^SY^R%96UG\1_$-QJ/B;5,+X>\#>'+8WNLZM(QPJ0VR'(#
M'@.^U,\;LX! /8F954LQ  &23VKY4^,7_!2Z#7?'=W^SW^P-\-W^,?Q#@/EZ
MA=:?/L\/>'B21YE]?@[#M.?W4;98JR;E? KEU^ '[;O_  428:I^U]K]W\'O
MA5<'=!\(_"6H_P#$XUB$\@:K?*/W:,/O01@9!PRHZAJ^J_@[\$OA+^S[X$M/
MAG\%?A_IGAO0[(?N=/TNW"*6P 7=OO22' R[DLW4DT ?.WPJ_P"":=]X\\;V
M?Q^_X*)_$L?%SQM;/YNE^'WA,?ACPZ3SLM+$@+,1T,LJY;"DIN&X_6$44<,:
MPPQJB(H5$48"@= !VIU% !7"?M'?L_\ @K]I?X4:C\+/&T6V.Y7S+"^1 9+&
MZ4'RYTSW!)!'&Y2RG@UW=%73J3I34X.S6PI14E9GX7?&SX,^.?@#\2=2^%WQ
M"TTV^H:?+@2*#Y=S$?N31D_>1AR#]0<$$#E*_8W]M[]C'PI^US\/?LJM#8>*
MM*C9_#^LLG )Y-O+CDQ.?J4/S#/*M^17C_P!XP^%WC"_\!>/=!GTW5M,G,5Y
M9W"X96[$'HRD8(89# @@D&OT3*LSIYA1UTFMU^J\OR/!Q.'E0GY,QZ***]4Y
M@HHHH ***U? _A.^\<^+;#PGIQVR7MP$:3;GRT'+OCN%4,V/:ANR ]R_9'\
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MV%H\OB33YVAU#1?"^F7FLR6DJG#QS/90RQ0R*>&C=U<'@C(J[^RK_P %X?\
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M/OX4:5XXC\=^&;O5[;49M7T*&&P+Z;,T-QLE6X9F!93MR@R.N*\>_P"#=_\
MX+L^-/\ @KSX;\:_#WX[_#/1?#OQ \!P6EW<77AGS4T_5[*X:1!*D4SR/!)&
M\8#J796\U2N.5'YK_P#!!W_E:4^,/_8P_$3_ -.4E ']*U?./[9G_!6__@GC
M_P $^/'FE_#+]L+]HZU\&:YK6D#5-,L)_#VI7AGM#*\7F[K2VE5?GC=<$@_+
MG&"#7T=7\T7_  >OPFX_X*#?":!2 7^$$:@GMG5KX4 ?T8_ SXY?"?\ :6^$
M6@?'CX&>-;;Q%X2\4:>M[H6M6B.B74#$C.V15="""K(ZJRLI5@""*^<?B/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6D4L6 4$U]VZGJ>FZ+IUQK&L:A!:6EI \UU=7,HCCAC4%F=V8@*H ))/  H
M^=_^'/'_  2@_P"D;GP/_P##8Z9_\9KH/A7_ ,$T/^">'P-\?Z=\5?@S^P]\
M*?"OB;2)'?2O$'A[P'86EY9L\;1L8YHH@Z$H[J<$9#$=#7$_L._\%E_^"?O_
M  48^+FO_!']DKXN7OB/7O#6DR:EJD<OAR\M81:I<1VYD2::-4D'F2IC:3D'
M(XKZEH \E^._[!'[$7[47C"W^(/[2/[)'PY\>:[::<FGVNL>+O!UGJ%S%:))
M)(L"R3QLPC#RRL%!P#(Q[FN+B_X(^?\ !*6"59H?^";_ ,$4=&#(R_#+3 01
MT(_<U]'=.M?GY^TE_P '/'_!'[]F?XE7GPHUOX_:AXIU73+EK?59/ WAZ;4;
M2UE4X9/M(VPRD'.?*>0 @CJ,4 ?97QZ_9C_9S_:F\,VG@O\ :5^!?A/Q]I%A
M?B]L=,\7Z!;ZC!;W(1HQ,B3HRJ^QW7<!G#D=S6EX(^"OP@^&GPLM_@=\//AA
MH.A^#;6QELK;PKI6E10:?%;2%C)"MNBA C%WRH&#N.>M><?L._\ !1C]C;_@
MHW\/KKXD?L@_&JP\56FFRI%K-AY,MK?:9(X)5;BUG5)8@VUMKE=C[&V,VTXY
M?]OS_@KQ^P%_P3/ALK3]K+XYV^DZWJEL;C2O"NE64M_JEU#DKYOD0*QBC)5@
M))2B,48!B010!/\ \.>/^"4'_2-SX'_^&QTS_P",UW_P!_8E_8\_94U74-=_
M9F_9=\ _#^]U:W2#5+OP=X3M-.DNXD8LJ2-!&I=0Q) .0":^/?V?/^#IC_@C
MK^T#X]L_AS'\<]8\&WVHW"P6%SX[\-RV-G+(Q "M<H9(8!S]Z9HUX^]TS^AY
MN+<6_P!J,Z>5LW^9N&W;C.<],8[T /K@/!O[*G[,WP[^,FM_M$^ _@!X.T?Q
M]XEA>+Q#XTTWP[;PZIJ4;LCND]TJ"652T49(9B"8U_NBOC_]H_\ X.<O^".O
M[-GC6\^'FJ_M(W'BW5=/F:*_3P%H,^IV\+KD%1=*%MY3D8_=R/@]<5]*?L$_
MM_\ [.'_  4E^!C_ +1'[+FN:E?^&XM;GTF:35M*DLYH[N%(G="C]0%FC.X9
M!SUX- '<_'C]G?X$_M0_#RX^$_[1?PB\/>-O#=U*LLNC>)=*CNX!*N=LJK(#
MLD7)VNN&7)P17#?LN?\ !.+]A/\ 8IU:^\1?LK?LK>#?!.J:C"8;W5]'TE1>
M2PE@QB^T/NE$9(!\L,%RH..!7M=% !1110!\I?&GXK?M^_M!_%36_P!GK]E+
MX:2?##P]HMZ;+Q#\9?'%DLCR\ G^R+,$BXRI!69SLY(/EL :[S]E/_@G[\!_
MV5+VZ\<:3;W_ (J\?:KE_$'Q'\7W)O=8OY&&'_?/GR4/39'@$ ;BQ&:]QHH
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M &-QQ_$3DD]R2:B6KL)NR+E%%%(@**** "BBB@ HHHH **** "BBB@ HHHH
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MXN^(FJ36EC'X5L97MM-2*UFN&GNIY51%4B$H$0O)N890+EA[3^UE^P#^Q?\
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M22$BB4*N2220,DDDY))H Z"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1\')']%-?S3?\'EH'_#T_P"#K8Y/PDT[)_[CFI5_2S0 4444 %%%% !1110
M4444 %%%% !5'Q-X8\.^,]!NO"WBW0[34M-O8C%=V-] LL4R'LRL"#5ZBFFT
M[H-S\_?VL?\ @CY/')<^-_V5KP.AS)+X0U&XPR^UM.YY]DD/K\YX6OA;Q7X1
M\4^!-?N/"WC3P[>Z5J5H^VYL=0MFBEC/NK 'Z'O7[UUP_P ;?V</@M^T1H?]
MA_%OP'9ZH$0K:WI7R[JVSWCF7#ISSC.TXY!KZ/ <15Z"4,0N9=^O_!_K4\^O
M@(3UAH_P/RM_9 \ !Y;WXD:A!_J\VFF[A_$0#+(.XX(0$<'<X[5[M7M6N_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?'&S\/7.KJ[:)H-M:RWNI:B%.&:*V@5GV \&5@L8) + D"@"E_PYX_X)0?\
M2-SX'_\ AL=,_P#C-?*G_!PU_P $W_VM?V_?A'\ ?V'OV-OA19VGPVL/'4-S
MX\UBUU33[&T\*Z=;01V5H5M99HY)XXX;J[<16Z/C[.HP"4%;/P<_X.N?^"-?
MQ=\:VW@F]^,_B/P>]Y,L5MJ?C'PG/;61=C@;YHC*L*^KR[$7J6 YK]&M+U33
M-;TRWUK1=1@O+.\@2>TN[699(IXG4,KHRDAE((((."#D4 <]\'_@W\/?@3\'
M/#?P&^&N@QV/ACPIX?MM%T?3P 1':00K$BL<?,=JC)/+$DGDU\\:/_P0N_X(
M_P"AZ_'XEL?^"=_PP:YCE\Q$NO#RSP;LYY@E+1$>Q7'M7U9<W,%G;27=U*L<
M42%Y'8\*H&23^%?G%\2_^#KS_@B[\//$,GA[3?CQXA\4F&39->^&?!%\]NK
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MG.<FOI/PMX0\)^!_#%EX)\%>%].T?1M-M5MM.TC2K*.WM;6%1A8HXHP$1 .
MJ@ 5HT4 >6? /]AS]C3]E;7K[Q3^S1^RM\/O &I:G:"UU&_\'^$K33IKF ,'
M$4CP1J73< VT\9 -);?L,_L8V7QW/[45I^RI\/8OB2UZ]X?'D?A&T&KFX:,Q
M-+]K$?F[S&2A;=DJ2.E>J44 >5_'+]AG]C']ISQ?8_$#]HS]E3X>^.M=TRR6
MST[6/%GA&TU"YMK=9'D6*.2:-F5 [NP4' 9R>I->J444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !5;5]%T?7[%],UW2K:]MG^_!=0+(C?4,"*LT4T
MVG= TF>4^,?V.OA!XF+7&D6EUHT[<[K";,9/NCY 'LNVO,_$_P"POXXL"TGA
M3Q7I^H(.B72-;R'V'WE/XD5]145Z=#.<QH*RG=>>O_!_$Y9X/#5/LV]#XCUW
M]F_XW>'F(N_A[?3*.C6 6XS^$18_I7*:GX:\1Z(Q36?#][:$=1=6CQD?]] 5
M^@]%>E3XFKKXZ:?HVO\ ,YI99!_#)GYUT5^A%UX=\/WK^9>Z'9S-_>EM48_J
M*J_\('X&SG_A#-)_\%T7_P 372N)Z?6D_O\ ^ 9?V7+^;\#X!J>QTO4]4D\K
M3=.GN'_NP0LY_("OOVV\(^%+)MUGX8TZ(^L5E&O\A5Z...)!'%&JJ.BJ,"IE
MQ.OLTOQ_X UE;ZR_#_@GPQHGP+^,/B$C^S/ASJN#T>XM3"I_X%)M'ZUV_AO]
MB;XL:L5DUZ\TW2D_B66X,T@^@C!4_P#?5?65%<=7B3&ST@E'\?Z^XWAEM!?$
MVSQ3PC^P_P##K2=L_BW6[[5Y!]Z-#]GA/X*2_P#X\*]5\*^ _!G@>U^R>$O#
M-G8(1AC;P ._^\WWF_$FM:BO(Q&.Q>*_BS;\NGW;'73H4:7PQL%%%%<IJ>7_
M !@_8F_9%^/OFR_&#]G#P?KES-GS-1N=#A6[YZXN$"RK^#"O%G_X(^?"/P$[
M7G[*7[0_Q;^$,BDM#8>%/&\\^G$^DEM=^9YBY_A+BOKFB@#Y$_X55_P6.^"X
MSX#_ &G/AA\7K&+I:?$#PG+HMZR?W$ET]BC/VW2<'J:/^'A/[7/PF'E_M1_\
M$Q?B#:01<2ZU\+]2MO$T#+WE,4122).Y#$D 5]=T4 ?-/PX_X*]?\$^OB)J7
M_"/7/Q_L_"NKHP6YTCQU8SZ-+;L?X7:Z1(L_1S7T+X7\7>%/&^D1^(/!?B?3
MM7L)?]5>Z7>QW$+_ $>,E3^=9?Q(^#/P@^,6F_V/\6_A9X=\46H4J+?Q!HL%
MXBCV$J-C\*^>O%'_  1J_8AN]8D\5?"CP_XH^%^MR?\ ,:^&?B^[TR9?3:FY
MX5Q[1B@#ZJHKY$'['O\ P4D^#Y\S]G[_ (*0OXFLHO\ 4^'_ (P>$8;_ 'XZ
M;]0@(N#Z'"CUH_X:A_X*G?!SY/CC_P $_M"\=6<7_'QKOP@\:+D8[I8WH\^3
M/H"* /KNOGG_ (*3_P#!,O\ 9R_X*I?!31_@)^TW?>)8-#T3Q3#K]F_A?4X[
M2<W<=M<6ZAGDBD!39=29& <[3GC!YSPC_P %@_V4KSQ+8^!/C%X?^(/PK\0:
MC<I;6>C?$;P)>6<DT[,%"*\2RQ\D\%F -?5- 'YI?L\_\&IG_!,/]F7X\>#?
MVBOASK_Q2?Q!X&\3V.NZ*FI>*[:6W:ZM9TFB$J+9J63>@R P)&>15#_@OQ_P
M<,^&/^"5MO\ \,W? _PB?$/QIUW0EO[.34[9AI?AZTE:1([N8\?:92T;[($.
MWY=TC* J2?IY7@'[2O\ P2Q_X)Z?MB?$9?B[^TY^R?X5\9^)5TZ*P76-9MY&
MF%M&6*195P-JEW(X_B- '\ZG_!(3]H[_ ().^%?VB[G_ (*4_P#!8#]KW7/'
M?QDNM=;5M'\-2^"]4O[?3[T-\E_>3+;^7/.FU?)AC_<P!4(W,$6']V_VG/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*QVSW(MH7.R93<K<^<G_ "TD21"<$8 //_\ @JU^W1_P3N_X*T^&?@=\'_V
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M ()'? ?1_"7C_P#::U^R'C$:7<3SWAT2.<I"MY>7#R7#12S"0EGD94@MKO(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5X!XM_P""4G_!,CQ]XKU/QUXW_P""?OP<
MU?6M:U":_P!7U;4OAUITUQ>W4TC22SRR/"6>1W9F9B226)/6O?Z* /%O@_\
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M!7PB^!7A+PSX+U 7(OO"FA:!;VNG7 N%V3A[>-!&WF+PV1\PX.:\J_X<\?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.G?%&ZU&]O[CQK;P.+V2YNXY([F4L6QND2:16XZ.: /<**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\,^*? VFP6\6F^&M=TM+FVLQ;Q&*!H0X)B=(R4612' 8@'DY /QZ_P""G_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
@ !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>imagea.jpg
<TEXT>
begin 644 imagea.jpg
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J=PU<#\/^4J5*E2I5JE2I4J7FMIS['Q-1/-?G =S"     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
